Section 51

EurekaMag PDF full texts Chapter 50,057


Hastings, P.A. 2001: Protemblemaria perla, a new species of tube blenny (Perciformes: Chaenopsidae) from the tropical eastern Pacific. Revista de Biologia Tropical 49(Suppl 1): 125-132
Paul, D.; Miyake, H.; Shinoda, S.; Tsukube, H. 2006: Proteo-dendrimers designed for complementary recognition of cytochrome c: dendrimer architecture toward nanoscale protein complexation. Chemistry 12(5): 1328-1338
Variati, G. 1964: Proteoanabolic Medication in the Area of Antiblastic Gynecologic Therapy. Annali di Ostetricia e Ginecologia 86: 742-750
Angelova, A.; Angelov, B.; Papahadjopoulos-Sternberg, B.; Ollivon, M.; Bourgaux, C. 2005: Proteocubosomes: nanoporous vehicles with tertiary organized fluid interfaces. Langmuir: the Acs Journal of Surfaces and Colloids 21(9): 4138-4143
Banfield, J.F.; Verberkmoes, N.C.; Hettich, R.L.; Thelen, M.P. 2005: Proteogenomic approaches for the molecular characterization of natural microbial communities. Omics: a Journal of Integrative Biology 9(4): 301-333
Takemae, H.; Ueda, R.; Okubo, R.; Nakato, H.; Izumi, S.; Saigo, K.; Nishihara, S. 2003: Proteoglycan UDP-galactose:beta-xylose beta 1,4-galactosyltransferase i is essential for viability in Drosophila melanogaster. Journal of Biological Chemistry 278(18): 15571-15578
Glant, T.T.; Mikecz, K. 2004: Proteoglycan aggrecan-induced arthritis: a murine autoimmune model of rheumatoid arthritis. Methods in Molecular Medicine 102: 313-338
Connon, C.J.; Siegler, V.; Meek, K.M.; Hodson, S.A.; Caterson, B.; Kinoshita, S.; Quantock, A.J. 2003: Proteoglycan alterations and collagen reorganisation in the secondary avian cornea during development. Ophthalmic Research 35(4): 177-184
Quantock, A.J.; Padroni, S.; Connon, C.J.; Milne, G.; Schanzlin, D.J. 2003: Proteoglycan alterations in the rabbit corneal stroma after a lamellar incision. Journal of Cataract and Refractive Surgery 29(4): 821-824
Uyama, T.; Kitagawa, H.; Sugahara, K. 2003: Proteoglycan core glycosyltransferases. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 48(8 Suppl): 1019-1026
Patwari, P.; Cook, M.N.; DiMicco, M.A.; Blake, S.M.; James, I.E.; Kumar, S.; Cole, A.A.; Lark, M.W.; Grodzinsky, A.J. 2003: Proteoglycan degradation after injurious compression of bovine and human articular cartilage in vitro: interaction with exogenous cytokines. Arthritis and Rheumatism 48(5): 1292-1301
Von den Hoff, H.W.; van Kampen, G.P.; van der Korst, J.K. 1993: Proteoglycan depletion of intact articular cartilage by retinoic acid is irreversible and involves loss of hyaluronate. Osteoarthritis and Cartilage 1(3): 157-166
Taskiran, E.; Taskiran, D.; Lok, V. 2005: Proteoglycan fragments in anterior cruciate ligament reconstructed knees: a comparative study of two different surgical techniques. Knee Surgery Sports Traumatology Arthroscopy: Official Journal of the Esska 13(5): 385-392
Kim, G.-Y.; Han, M.-G.; Song, Y.-S.; Shin, B.-C.; Shin, Y.-I.; Lee, H.-J.; Moon, D.-O.; Lee, C.-M.; Kwak, J.-Y.; Bae, Y.-S.; Lee, J.-D.; Park, Y.-M. 2004: Proteoglycan isolated from Phellinus linteus induces toll-like receptors 2- and 4-mediated maturation of murine dendritic cells via activation of ERK, p38, and NF-kappaB. Biological and Pharmaceutical Bulletin 27(10): 1656-1662
Wheaton, A.J.; Borthakur, A.; Shapiro, E.M.; Regatte, R.R.; Akella, S.V.S.; Kneeland, J.B.; Reddy, R. 2004: Proteoglycan loss in human knee cartilage: quantitation with sodium MR imaging--feasibility study. Radiology 231(3): 900-905
Sauerland, K.; Raiss, R.X.; Steinmeyer, J. 2003: Proteoglycan metabolism and viability of articular cartilage explants as modulated by the frequency of intermittent loading. Osteoarthritis and Cartilage 11(5): 343-350
De Mattei, M.; Fini, M.; Setti, S.; Ongaro, A.; Gemmati, D.; Stabellini, G.; Pellati, A.; Caruso, A. 2007: Proteoglycan synthesis in bovine articular cartilage explants exposed to different low-frequency low-energy pulsed electromagnetic fields. Osteoarthritis and Cartilage 15(2): 163-168
Glant, T.T.; Finnegan, A.; Mikecz, K. 2003: Proteoglycan-induced arthritis: immune regulation, cellular mechanisms, and genetics. Critical Reviews in Immunology 23(3): 199-250
Tannock, L.R. 2006: Proteoglycans can mediate renal lipoprotein retention. Diabetologia 49(5): 1115-1116
Höke, A. 2005: Proteoglycans in axonal regeneration. Experimental Neurology 195(2): 273-277
Goldberg, M.; Rapoport, O.; Septier, D.; Palmier, K.; Hall, R.; Embery, G.; Young, M.; Ameye, L. 2003: Proteoglycans in predentin: the last 15 micrometers before mineralization. Connective Tissue Research 44(Suppl 1): 184-188
Kovalszky, I.; Dudás, J.óz.; Gallai, M.ón.; Hollósi, P.ét.; Tátrai, P.ét.; Tátrai, E.ô; Schaff, Z. 2004: Proteoglycans in the liver. Magyar Onkologia 48(3): 207-213
Motose, H.; Sugiyama, M.; Fukuda, H. 2005: Proteoglycans inducing plant cell differentiation. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 50(4): 350-355
Ernst, G.ün.; Melle, C.; Schimmel, B.; Bleul, A.; von Eggeling, F. 2006: Proteohistography--direct analysis of tissue with high sensitivity and high spatial resolution using ProteinChip technology. Journal of Histochemistry and Cytochemistry: Official Journal of the Histochemistry Society 54(1): 13-17
Hanc, O. 1953: Proteohormones. Ceskoslovenska Farmacie 2(4): 127-132
Murakami, M.; Ozawa, Y.; Funahashi, S. 1963: Proteolipid from Beef Heart Muscle. Ii. Chemical Composition and Subcellular Distribution. Journal of Biochemistry 54: 166-172
Murakami, M.; Sekine, H.; Funahashi, S. 1962: Proteolipid from beef heart muscle. I. Application of organic dialysis to preparation of proteolipid. Journal of Biochemistry 51: 431-435
Das, M.L.; Crane, F.L. 1964: Proteolipids. I. Formation of Phospholipid-Cytochrome C Complexes. Biochemistry 3: 696-700
Das, M.L.; Myers, D.E.; Crane, F.L. 1964: Proteolipids. Ii. Isolation of a Phosphatidylethanolamine Required for Lipid-Cytochrome C Formation. Biochimica et Biophysica Acta 84: 618-620
Dumazert, C. 1950: Proteolysates in external usage. Marseille Chirurgical 2(5): 698-703
Foa, C. 1950: Proteolysates in parenteral, duodenal, and rectal feeding. Acta Anaesthesiologica Belgica 1(5): 377-388
Romagnolo, L. 1962: Proteolysates in the therapy and prevention of protein deficiencies. Il Corriere Dei Farmacisti 17: 3-6
Weill, J.; Bernfeld 1951: Cushing disease and hypercorticism. Journal des Praticiens; Revue Generale de Clinique et de Therapeutique 65(4): 37-39
Druzhinin, I.P.; Benevolenskii, V.N. 1964: Proteolysis in the Blood of Rats Exposed to Ionizing Radiations. Radiobiologiia 4: 384-387
Bernfeld, P.; Kelley, T.F. 1964: Proteolysis of Human Serum Beta-Lipoprotein. Journal of Biological Chemistry 239: 3341-3346
Desbals, B.; Raynaud, P. 1961: Proteolysis and deamination in the stomach of ruminants. Action of toluene on bacterial metabolism. Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 155: 1579-1581
Craps, L.; Inderbityin, T. 1960: Proteolysis as a possible mechanism in cutaneous anaphylaxis. Archiv für Klinische und Experimentelle Dermatologie 211: 320-323
Frankenberg, M.V.; Forman, D.T.; Frey, W.; Bunzendahl, H.; Thurman, R.G. 1998: Proteolysis but not ICAM-1 expression in fatty liver increased in tissue harvesting--role of Kupffer cells. Langenbecks Archiv für Chirurgie. Suppl. Kongressband. Deutsche Gesellschaft für Chirurgie. Kongress 115(Suppl I): 575-579
Collins, K.A.; Furuyama, S.; Biggins, S. 2004: Proteolysis contributes to the exclusive centromere localization of the yeast Cse4/CENP-A histone H3 variant. Current Biology: Cb 14(21): 1968-1972
Tsirul'nikov, K.B.; Mel'nikov, E.E.; Rotanova, T.V. 2003: Proteolysis coupled with ATP. Regulation of activity of proteolytic centers of Escherichia coli lon protease. Bioorganicheskaia Khimiia 29(5): 486-494
Hornebeck, W.; Emonard, H.é; Maquart, F.ço.-X.; Bellon, G. 2003: Proteolysis directed by the extracellular matrix. Journal de la Societe de Biologie 197(1): 25-30
Bramstedt, F. 1953: Proteolysis in anacid stomach. Die Medizinische 21(20): 675-678
Ward, D.E.; Shockley, K.R.; Chang, L.S.; Levy, R.D.; Michel, J.K.; Conners, S.B.; Kelly, R.M. 2002: Proteolysis in hyperthermophilic microorganisms. Archaea 1(1): 63-74
Bramstedt, F. 1955: Proteolysis in the antacid stomach. Medicina 23(3): 148-160
Crosata, M. 1960: Proteolysis in the blood serum of premature infants. Minerva Pediatrica 12: 437-441
Yatzidis, H. 1959: Proteolysis in the blood; its mechanism, its study by present-day methods and its physiopathology. Revue Francaise d'Etudes Cliniques et Biologiques 4(4): 383-391
Skorobogatova, L.I. 1951: Proteolysis in the tissue of extremities of certain amphibia with various regenerative properties in various periods following amputation. Doklady Akademii Nauk SSSR 79(6): 1053-1056
Simmons, G.; Rennekamp, A.J.; Bates, P. 2006: Proteolysis of SARS-associated coronavirus spike glycoprotein. Advances in Experimental Medicine and Biology 581: 235-240
Panasenko, O.M.; Aksenov, D.V.; Mel'nichenko, A.A.; Suprun, I.V.; Yanushevskaya, E.V.; Vlasik, T.N.; Sobenin, I.A.; Orekhov, A.N. 2005: Proteolysis of apoprotein B-100 impairs its topography on LDL surface and reduces LDL association resistance. Bulletin of Experimental Biology and Medicine 140(5): 521-525
Matsumura, K.; Zhong, D.; Saito, F.; Arai, K.; Adachi, K.; Kawai, H.; Higuchi, I.; Nishino, I.; Shimizu, T. 2005: Proteolysis of beta-dystroglycan in muscular diseases. Neuromuscular Disorders: Nmd 15(5): 336-341
Yon, J. 1958: Proteolysis of beta-lactoglobulin by chymotrypsin. II. Kinetic and thermodynamic studies on the reaction in the presence of ammonium; comparison with other proteolyses. Bulletin de la Societe de Chimie Biologique 40(2-3): 379-396
Labeyrie, F. 1956: Proteolysis of beta-lactoglobulin by trypsin. I. Critical study on measurement methods; titration of apparent carboxylic and alpha-amino groups, and determination of products soluble in trichloroacetic acid. Bulletin de la Societe de Chimie Biologique 38(11): 1271-1285
De Mende, S.; Labeyrie, F. 1956: Proteolysis of beta-lactoglobulin by trypsin. II. Ultracentrifugation and paper electrophoresis of hydrolysates. Bulletin de la Societe de Chimie Biologique 38(11): 1287-1300
Hockstein, N.G.; Cohen, N.A.; Palmer, J.N. 2005: Proteolysis of beta-trace Protein?. Otolaryngology--head and neck surgery: official journal of American Academy of Otolaryngology-Head and Neck Surgery 133(2): 310; author reply 310-1
Garnier, J. 1958: Proteolysis of casein by rennet; application of the potentiometric method at pH7. Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences 247(18): 1515-1518
Green, G.H. 1957: Proteolysis of collagen. Nature 180(4576): 93
Ryu, O.H.; Choi, S.J.; Firatli, E.; Choi, S.W.; Hart, P.S.; Shen, R.-F.; Wang, G.; Wu, W.W.; Hart, T.C. 2005: Proteolysis of macrophage inflammatory protein-1alpha isoforms LD78beta and LD78alpha by neutrophil-derived serine proteases. Journal of Biological Chemistry 280(17): 17415-17421
Yon, J. 1958: Proteolysis of native beta-lactoglobulin. I. Kinetic and thermodynamic study of the reaction. Bulletin de la Societe de Chimie Biologique 40(1): 45-58
Stuttgen, G.; Hofmann, N.; Simmich, W. 1957: Proteolysis of normal and pathologically changed skin by endopeptidases. Archiv für Klinische und Experimentelle Dermatologie 205(4): 381-388
Lindstedt, K.A.; Kovanen, P.T. 2004: Proteolysis of pericellular matrix: a process linking inflammation to plaque destabilization and rupture. Arteriosclerosis Thrombosis and Vascular Biology 24(12): 2205-2206
Poole, A.R.; Nelson, F.; Dahlberg, L.; Tchetina, E.; Kobayashi, M.; Yasuda, T.; Laverty, S.; Squires, G.; Kojima, T.; Wu, W.; Billinghurst, R.C. 2003: Proteolysis of the collagen fibril in osteoarthritis. Biochemical Society Symposium 70: 115-123
Tul'chinskii, M.N. 1950: Proteolysis of wheat flour by lactic acid dough bacteria. Mikrobiologiia 19(5): 434-437
Garde, S.; Gaya, P.; Fernández-García, E.; Medina, M.; Nuñez, M. 2003: Proteolysis, volatile compounds, and sensory evaluation in Hispánico cheese manufactured with the addition of a thermophilic adjunct culture, nisin, and calcium alginate-nisin microparticles. Journal of Dairy Science 86(10): 3038-3047
Ades, S.E. 2004: Proteolysis: Adaptor, adaptor, catch me a catch. Current Biology: Cb 14(21): R924-R926
Dean, R.T.; Dunlop, R.; Hume, P.; Rodgers, K.J. 2003: Proteolytic 'defences' and the accumulation of oxidized polypeptides in cataractogenesis and atherogenesis. Biochemical Society Symposium 70: 135-146
Rao, K.C.S.; Carruth, R.T.; Miyagi, M. 2005: Proteolytic 18O labeling by peptidyl-Lys metalloendopeptidase for comparative proteomics. Journal of Proteome Research 4(2): 507-514
Reynolds, K.J.; Yao, X.; Fenselau, C. 2002: Proteolytic 18O labeling for comparative proteomics: evaluation of endoprotease Glu-C as the catalytic agent. Journal of Proteome Research 1(1): 27-33
Miyagi, M.; Rao, K.C.S. 2007: Proteolytic 18O-labeling strategies for quantitative proteomics. Mass Spectrometry Reviews 26(1): 121-136
Heully, F.; Larcan, A.; Dornier, R.; Grosdidier, J.; Metz, R. 1964: Proteolytic Antienzymes in the Treatment of Developmental Attacks of Pancreatitis. Annales Medicales de Nancy 3: 430-448
Lindström, M.; Hielm, S.; Nevas, M.; Tuisku, S.; Korkeala, H. 2004: Proteolytic Clostridium botulinum type B in the gastric content of a patient with type e botulism due to whitefish eggs. Foodborne Pathogens and Disease 1(1): 53-57
Hasegawa, T. 1964: Proteolytic Digestion of Molluscum Contagiosum Virus with Pronase as Revealed by Electron Microscopy. Hifuka Kiyo. Acta Dermatologica 59: 275-276
Tishkoff, G.H. 1964: Proteolytic Digestion of Purified Bovine Prothrombin: Formation of Active Fragments. Thrombosis et Diathesis Haemorrhagica 10: 390-399
Chukhlovina, M.G. 1963: Proteolytic Enzyme Therapy for Children with Chronic Pneumonia. Pediatriia 42: 26-31
Autuori, F.; Nardelli, M.B.; Gabriel, A. 1965: Proteolytic Enzymes and Phosphatases during Regeneration of Planaria Fragments. Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences 260: 995-998
Haschen, R.J.; Farr, W.; Groh, F. 1965: Proteolytic Enzymes and Protein Metabolism in Rabbit Erythrocytes during cell Maturation in Vivo. Acta Biologica et Medica Germanica 14: 205-215
Blackwood, C.E.; Mandl, I.; Long, M.E. 1965: Proteolytic Enzymes and their Inhibitors in Human Gynecological Tumors. American Journal of Obstetrics and Gynecology 91: 419-429
Katz, I.A.; Tillman, P. 1965: Proteolytic Enzymes for Foot Problems in a State Institution: a Preliminary Report. Journal of the American Podiatry Association 55: 285-286
Pilipchuk, N.S.; Veremeenko, K.N. 1963: Proteolytic Enzymes in the Combined Treatment of Patients with Tuberculosis and Suppurative Diseases of the Lung and Pleura. Klinicheskaia Meditsina 41: 42-51
Benini, A. 1965: Proteolytic Enzymes in the Medical Treatment of Parodontopathies. Rivista Italiana di Stomatologia 20: 200-210
Nagel, W.; Willig, F. 1964: Proteolytic Enzymes in the Pancreas in Normal and Pathological Conditions. Klinische Wochenschrift 42: 400-402
Trickett, P. 1964: Proteolytic Enzymes in Treatment of Athletic Injuries. Applied Therapeutics 6: 647-652
Thorek, P.; Pandit, J.K. 1964: Proteolytic Enzymes in Wound Repair; Immediate Postoperative effects. Applied Therapeutics 6: 323-325
Hofmann, T.; Shaw, R. 1964: Proteolytic Enzymes of Penicillium Janthinellum. I. Purification and Properties of a Trypsinogen-Activating Enzyme (Peptidase A). Biochimica et Biophysica Acta 92: 543-557
Shaw, R. 1964: Proteolytic Enzymes of Penicillium Janthinellum. Ii. Properties of Peptidase B. Biochimica et Biophysica Acta 92: 558-566
Loukas, A. 2002: Proteolytic Enzymes as Therapeutic Targets - Keystone Symposium. Targeting ICE and ACE. 3-8 February 2002, Keystone, CA, USA. IDrugs: the investigational drugs journal 5(3): 220-221
Arcangeli, P.; Digiesi, V.; Arcangeli, A. 1963: Proteolytic Processes and Purpura induced in Hypertensive Patients. Experimental Study. I. Influence of Trypsin on Hemorrhagic Manifestations of the Tourniquet test in Hypertensive Patients. Rivista Critica di Clinica Medica 63: 272-286
Arcangeli, P.; Arcangeli, A.; Digiesi, V. 1963: Proteolytic Processes and Purpura induced in Hypertensive Patients. Ii. Inhibition of the Hemorrhagic Manifestations of the Tourniquet test by Administration of Inhibitors of Proteolysis. Rivista Critica di Clinica Medica 63: 287-291
Arcangeli, P.; Digiesi, V.; Arcangeli, A. 1964: Proteolytic Processes and Purpura Provoked in Hypertensives. Experimental Research. 3. Influence of Adrenalin on Manifestations Provoked in Hypertensives by Venous Stasis. Rivista Critica di Clinica Medica 64: 314-319
Digiesi, V.; Arcangeli, A. 1964: Proteolytic Processes and Purpura Provoked in Hypertensives. Iv. Influence of Thyroxin on Hemorrhagic Manifestations of the Tourniquet test in Hypertensives. Rivista Critica di Clinica Medica 64: 320-330
Gonashvili, S.G. 1964: Proteolytic Properties of the Latex from the Fig Tree (Ficus Carica Z.). Voprosy Pitaniia 23: 26-30
Azevedo, M.P.; Martirani, I. 1949: Proteolytic action of Bothrops jararaca venom. I. Effect on hemoglobin and casein. Memorias do Instituto Butantan 22: 31-46
Martirani, I.; Azevedo, M.P. 1949: Proteolytic action of Bothrops jararaca venom. II. Effect on gelatin. Memorias do Instituto Butantan 22: 47-61
Gaburro, D. 1953: Proteolytic action of feces in infants. Acta Paediatrica Latina 6(4): 605-614
Serebrovskaia, I.A. 1956: Proteolytic action of renin preparations. Biokhimiia 21(4): 461-464
Wisner, F.; Ienistea, C.; Ascher Solomon, E. 1955: Proteolytic action of some acidolactic bacteria. Igiena 3: 39-47
Kanthasamy, A.G.; Kitazawa, M.; Kaul, S.; Yang, Y.; Lahiri, D.K.; Anantharam, V.; Kanthasamy, A. 2003: Proteolytic activation of proapoptotic kinase PKCdelta is regulated by overexpression of Bcl-2: implications for oxidative stress and environmental factors in Parkinson's disease. Annals of the new York Academy of Sciences 1010: 683-686
Chakraborti, T.; Das, S.; Chakraborti, S. 2005: Proteolytic activation of protein kinase Calpha by peroxynitrite in stimulating cytosolic phospholipase A2 in pulmonary endothelium: involvement of a pertussis toxin sensitive protein. Biochemistry 44(13): 5246-5257
Omata, R.R.; Hampp, E.G. 1961: Proteolytic activities of some oral spirochetes. Journal of Dental Research 40: 171-176
Hale, L.P. 2004: Proteolytic activity and immunogenicity of oral bromelain within the gastrointestinal tract of mice. International Immunopharmacology 4(2): 255-264
Gotoh, T.; Miyazaki, Y.; Sato, W.; Kikuchi, K.; Bentley, W.E. 2001: Proteolytic activity and recombinant protein production in virus-infected Sf-9 insect cell cultures supplemented with carboxyl and cysteine protease inhibitors. Journal of Bioscience and Bioengineering 92(3): 248-255
Cormia, F.E.; Dougherty, J.W.; Unrau, S.A. 1957: Proteolytic activity in dermatoses: preliminary observations on inflammation and pruritus. Journal of Investigative Dermatology 28(6): 425-433
Cormia, F.E.; Dougherty, J.W. 1960: Proteolytic activity in development of pain and itching. Cutaneous reactions to bradykinin and kallikrein. Journal of Investigative Dermatology 35: 21-26
Sabacka, M.; Jezek, P.; Kutalkova, O.; Tovarek, J. 1961: Proteolytic activity in epidemic hepatitis. Casopis Lekaru Ceskych 100: 1545-1548
Thorson, R.E. 1956: Proteolytic activity in extracts of the esophagus of adults of Ancylostoma caninum and the effect of immune serum on this activity. Journal of Parasitology 42(1): 21-25
Rossger, G. 1956: Proteolytic activity in fasting gastric juice. Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 11(10): 467-469
Koch, O.G.; Dedic, G.A. 1957: Proteolytic activity in molds. Biochemische Zeitschrift 328(7): 536-548
Dougherty, J.W.; Cormia, F.E.; Unrau, S.A. 1957: Proteolytic activity in pemphigus. I. the Pels-Macht test. A.M.A. Archives of Dermatology 75(6): 793-795
Dougherty, J.W.; Cormia, F.E.; Unrau, S. 1958: Proteolytic activity in pemphigus. II. Estimations in skin and blood. A.M.A. Archives of Dermatology 77(3): 281-284
Sequeiros, C.; López, L.M.I.; Caffini, N.és.O.; Natalucci, C.L. 2003: Proteolytic activity in some Patagonian plants from Argentina. Fitoterapia 74(6): 570-577
Herberts, G. 1962: Proteolytic activity in supravitally shocked lung tissue. Acta Oto-Laryngologica 54: 124-126
Surikova, E.I.; Grabovskaia, O.Z. 1959: Proteolytic activity of Actinomyces streptomycini Kras, and its relation to the form of nitrogen in culture media. Mikrobiologiia 28: 703-709
Gorbach, G.; Koch, O.G. 1955: Proteolytic activity of Aspergillus niger and the effects of trace elements on it. I. Aspergillus niger proteinase. Archiv für Mikrobiologie 23(3): 265-283
Gorbach, G.; Koch, O.G. 1955: Proteolytic activity of Aspergillus niger and the effects of trace elements on it. II. the effect of zinc, manganese and iron. Archiv für Mikrobiologie 23(3): 284-296
Rózga, A.; Kurnatowska, A.; Gołab-Lipińska, M. 2001: Proteolytic activity of Candida albicans strains isolated from women's genital organs with clinical diagnosis of mycosis. Wiadomosci Parazytologiczne 47(Suppl 1): 125-129
Niewiarowski, S. 1951: Proteolytic activity of bile. Medycyna Doswiadczalna i Mikrobiologia 3(4): 407-417
Schierge, M. 1952: Proteolytic activity of blood in liver disorders and other pathological conditions. Das Deutsche Gesundheitswesen 7(47): 1481-1487
Nefelova, M.V.; Lomovskaia, N.D. 1960: Proteolytic activity of deep cultures of albomycin-producing organisms in relation to the production of the antibiotic. Mikrobiologiia 29: 114-118
Smirnova, E.A.; Mashilova, G.M. 1962: Proteolytic activity of diphtheria bacteria. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 33: 10-14
Rolando-Ricci, V.; Queirolo, C.; Gargiulo, G. 1960: Proteolytic activity of epididymal adipose tissue in the normal and thyroxinized rat. Archivio "e. Maragliano" di Patologia E Clinica 16: 245-249
Pelikan, V.; Placer, Z. 1955: Proteolytic activity of gastric juice. Casopis Lekaru Ceskych 94(27): 742-746
Vartio, T. 1961: Proteolytic activity of human serum and urine at various pH's. Annales Medicinae Experimentalis et Biologiae Fenniae 39: 115-119
Izvekova, G.I. 2003: Proteolytic activity of microflora associated with digestive intestinal surface transportation of burbot Lota lota parasitized by Eubothrium rugosum. Zhurnal Evoliutsionnoi Biokhimii i Fiziologii 39(5): 424-429
Gerbi, C. 1950: Proteolytic activity of normal and ischemic kidneys of the rabbit. Archives of Biochemistry 26(3): 343-350
Brotskaia, S.Z. 1954: Proteolytic activity of pliable variation of Aspergillus niger. Mikrobiologiia 23(2): 153-158
Sterzl, J. 1953: Proteolytic activity of sera and leukocytes from animals immunized with proteins. Chekhoslovatskaia Biologiia 2(3): 138-145
Goisis, M.; Candotti, G. 1955: Proteolytic activity of the blood serum in pregnancy and puerperium. Annali di Ostetricia E Ginecologia 77(11): 1022-1024
Bate, J.G.; James, U. 1956: Proteolytic activity of the pancreas; transient depression in infancy. Archives of Disease in Childhood 31(160): 506-511
Crosato, M.; De Sario, P.N.; Piccotti, F. 1956: Proteolytic activity of the serum in childhood. Minerva Pediatrica 8(48): 1518-1522
Beckers, C. 1963: Proteolytic activity of thyroid enzymes in non-toxic goiter. Revue Francaise d'Etudes Cliniques et Biologiques 8: 559-564
Meyers, W.M.; Burdon, K.L.; Riley, M.N. 1957: Proteolytic activity of whole human serum following surgery. Journal of Laboratory and Clinical Medicine 49(3): 377-385
Harris, T.J.; von Maltzahn, G.; Derfus, A.M.; Ruoslahti, E.; Bhatia, S.N. 2006: Proteolytic actuation of nanoparticle self-assembly. Angewandte Chemie 45(19): 3161-3165
Lessner, F.H.; Venters, B.J.; Keiler, K.C. 2007: Proteolytic adaptor for transfer-messenger RNA-tagged proteins from alpha-proteobacteria. Journal of Bacteriology 189(1): 272-275
Skorepa, J.; Novak, S.; Pstruzinova, H. 1959: Proteolytic and anti-proteolytic activity of the human serum following intravenous injection of heparin. Sbornik Lekarsky 61: 264-266
Guzzon, V.; Scevola, M.E. 1957: Proteolytic and antiinflammatory effects of trypsin. Bollettino della Societa Italiana di Biologia Sperimentale 33(6): 813-816
Eley, B.M.; Cox, S.W. 2003: Proteolytic and hydrolytic enzymes from putative periodontal pathogens: characterization, molecular genetics, effects on host defenses and tissues and detection in gingival crevice fluid. Periodontology 2000 31: 105-124
Santome, J.A.; Tanturi, C. 1960: Proteolytic and necrosing activity of the euglobulinic fraction of the serum of dogs treated with atophan. Revista de la Asociacion Medica Argentina 74: 609-613
Friedl, P.; Wolf, K. 2003: Proteolytic and non-proteolytic migration of tumour cells and leucocytes. Biochemical Society Symposium 70: 277-285
Ivanova, E.N. 1952: Proteolytic and peptolytic properties of Proteus in food products. Gigiena i Sanitariia 1: 40-43
Salvidio, E.; Parreira Da Silva, F. 1954: Proteolytic and phosphatase ferments of human blood platelets. Quaderni di Clinica Ostetrica E Ginecologica 9: 113-118
Candeli, A.; Tronieri, A. 1952: Proteolytic bacteria and dental caries. Bollettino Dell'istituto Sieroterapico Milanese 30(7-8): 415-419
Devenyi, R.; Kovacs, K. 1956: Proteolytic bronchotherapy in chronic inflammations of the lung. Tuberkulozis Kerdesei 9(4): 156-159
Bovenschen, N.; van Stempvoort, G.; Voorberg, J.; Mertens, K.; Meijer, A.B. 2006: Proteolytic cleavage of factor VIIi heavy chain is required to expose the binding-site for low-density lipoprotein receptor-related protein within the A2 domain. Journal of Thrombosis and Haemostasis: Jth 4(7): 1487-1493
Carbonetti, N.H.; Mays, R.M.; Artamonova, G.V.; Plaut, R.D.; Worthington, Z.ë E.V. 2005: Proteolytic cleavage of pertussis toxin S1 subunit is not essential for its activity in mammalian cells. Bmc Microbiology 5: 7
Brinkman, H.J.M.; Mertens, K.; van Mourik, J.A. 2005: Proteolytic cleavage of protein S during the hemostatic response. Journal of Thrombosis and Haemostasis: Jth 3(12): 2712-2720
Neznanov, N.; Chumakov, K.M.; Neznanova, L.; Almasan, A.; Banerjee, A.K.; Gudkov, A.V. 2005: Proteolytic cleavage of the p65-RelA subunit of NF-kappaB during poliovirus infection. Journal of Biological Chemistry 280(25): 24153-24158
Furlan, M.; Furlan, M. 2004: Proteolytic cleavage of von Willebrand factor by ADAMTS-13 prevents uninvited clumping of blood platelets. Journal of Thrombosis and Haemostasis: Jth 2(9): 1505-1509
Lundqvist, M.; Andresen, C.; Christensson, S.; Johansson, S.; Karlsson, M.; Broo, K.; Jonsson, B-Harald. 2005: Proteolytic cleavage reveals interaction patterns between silica nanoparticles and two variants of human carbonic anhydrase. Langmuir: the Acs Journal of Surfaces and Colloids 21(25): 11903-11906
Lindenschmidt, T.O. 1953: Proteolytic course following partial or total gastrectomy. Langenbecks Archiv für Klinische Chirurgie . Vereinigt Mit Deutsche Zeitschrift für Chirurgie 276: 636-639
Mulay, D.N.; Urbach, F. 1958: Proteolytic debridement of hyperkeratoses of palms and soles. A.M.A. Archives of Dermatology 78(6): 758
Griffith, K.L.; Shah, I.M.; Wolf, R.E. 2004: Proteolytic degradation of Escherichia coli transcription activators SoxS and MarA as the mechanism for reversing the induction of the superoxide (SoxRS) and multiple antibiotic resistance (Mar) regulons. Molecular Microbiology 51(6): 1801-1816
McNaught, K.S.P. 2004: Proteolytic dysfunction in neurodegenerative disorders. International Review of Neurobiology 62: 95-119
Greuer, W.; Hess, E. 1956: Proteolytic effect of sterile tylose mucus. Zentralblatt für Chirurgie 81(12): 491-494
Niemann, A. 1957: Proteolytic effects of potato tuber juice. Ii. Hoppe-Seyler's Zeitschrift für Physiologische Chemie 306(4-6): 205-213
Lieberman, J.; Kurnick, N.B. 1963: Proteolytic enzyme activity and the role of desoxyribose nucleic acid (DNA) in cystic fibrosis sputum. Pediatrics 31: 1028-1032
Drake, M.P.; Giffee, J.W.; Harriman, H.; Ryer, R. 1957: Proteolytic enzyme activity in irradiation-sterilized meat. Science 125(3236): 23
Wagner, H. 1958: Proteolytic enzyme activity of amniotic fluid and of newborn urine. Geburtshilfe und Frauenheilkunde 18(4): 405-410
Miller, L.L.; Segal, H.L.; Plumb, E.J. 1957: Proteolytic enzyme activity. II. Gastric and urinary proteolytic activities at pH 1.5 and 3.5. Gastroenterology 33(4): 566-574
Sim, Y.C.; Nam, Y.S.; Shin, Y.H.; Shin, E.; Kim, S.; Chang, I.S.; Rhee, J.S. 2003: Proteolytic enzyme conjugated to SC-glucan as an enzymatic transdermal drug penetration enhancer. Die Pharmazie 58(4): 252-256
Bianchini, P. 1953: Proteolytic enzyme in Hartmannella castellanii; proposed new method for quantitative method of determination of gelatinasic activity. Archivio di Scienze Biologiche 37(3): 247-254
Jung, G. 1962: Proteolytic enzyme in the human ovary. Geburtshilfe und Frauenheilkunde 22: 960-964
Marsh, J.T.; Hilliard, J.; Liechti, R. 1954: Proteolytic enzyme system in sexual deviates. A.M.A. Archives of Neurology and Psychiatry 72(3): 341-347
Mackenzie, E.B. 1959: Proteolytic enzyme therapy and an unusual result following routine removal of wisdom teeth. Journal of the Royal Naval Medical Service 45: 95-99
Dakin, W.V. 1957: Proteolytic enzyme therapy in equine practice. Journal of the American Veterinary Medical Association 131(6): 289-291
Zlydnikov, D.M. 1961: Proteolytic enzyme therapy of patients with bronchial asthma and chronic non-specific pneumonia. Terapevticheskii Arkhiv 33: 62-67
Chung, S.M.; Wong, A.S. 1962: Proteolytic enzyme treatment of herpes simplex lesions of the rabbit cornea. American Journal of Ophthalmology 53: 75-79
Toto, P.D. 1959: Proteolytic enzyme-antibiotic preparations in the treatment of oral lesions. Oral Surgery Oral Medicine and Oral Pathology 12(6): 696-703
Laskowski, M. 1950: Proteolytic enzymes. Annual Review of Biochemistry 19: 21-42
Balls, A.K.; Jansen, E.F. 1952: Proteolytic enzymes. Annual Review of Biochemistry 21: 1-28
Linderstrøm-Lang, K.; Møller, K.M. 1953: Proteolytic enzymes. Annual Review of Biochemistry 22: 57-84
Desnuelle, P. 1954: Proteolytic enzymes. Annual Review of Biochemistry 23: 55-78
Schwert, G.W. 1955: Proteolytic enzymes. Annual Review of Biochemistry 24: 83-112
Fruton, J.S.; Mycek, M.J. 1956: Proteolytic enzymes. Annual Review of Biochemistry 25: 57-78
Jandorf, B.J.; Michel, H.O. 1957: Proteolytic enzymes. Annual Review of Biochemistry 26: 97-118
Hartley, B.S. 1960: Proteolytic enzymes. Annual Review of Biochemistry 29: 45-72
Spiegel, L.H. 1958: Proteolytic enzymes (intramuscular and topical); an aid in treatment of refractory dry sockets (localized acute alveolar osteomuelitis). Oral Surgery Oral Medicine and Oral Pathology 11(7): 692-696
Czarkowska-P Czek, B.; Przybylski, J.; Marciniak, A.; Pawłowska, M.; Juskowa, J.; Foroncewicz, B.; Mucha, K. 2004: Proteolytic enzymes activities in patients after myocardial infarction correlate with serum concentration of TGF-beta. Inflammation 28(5): 279-284
Laurentaci, G.; Oliva, V. 1960: Proteolytic enzymes and adhesional reactions of the peritoneal serous membranes. Minerva Chirurgica 15: 1271-1277
Veremeenko, K.N.; Dosenko, V.E.; Nagibin, V.S.; Kizim, A.I.; Moĭbenko, A.A. 2003: Proteolytic enzymes and apoptosis. Ukrains'kyi Biokhimichnyi Zhurnal 75(6): 10-24
Jung, G.; Kidess, A. 1962: Proteolytic enzymes and phosphatases in the corpus luteum and corpus rubrum of swine ovaries. Archiv für Gynakologie 196: 457-462
Travis, B.L.; Ferguson, J.H. 1951: Proteolytic enzymes and platelets in relation to blood coagulation. Journal of Clinical Investigation 30(1): 112-123
Baurys, W.; Jacobson, H.H. 1959: Proteolytic enzymes and prostatectomy. Journal of Urology 81(5): 676-680
Innerfield, I. 1956: Proteolytic enzymes and subsidence of chemically induced inflammation. Surgery 39(3): 426-433
Heyll, U.; Münnich, U.; Senger, V. 2003: Proteolytic enzymes as an alternative in comparison with nonsteroidal anti-inflammatory drugs (NSAID) in the treatment of degenerative and inflammatory rheumatic disease: systematic review. Medizinische Klinik 98(11): 609-615
Creemers, J. 2002: Proteolytic enzymes as therapeutic targets - Keystone Symposium. 3-8 February 2002, Keystone, CO, USA. IDrugs: the investigational drugs journal 5(3): 216-219
Emanuiloff, I. 1959: Proteolytic enzymes from Bac. mesentericus and their properties. Enzymologia 20(4): 173-182
Neal, R.A. 1956: Proteolytic enzymes in Entamoeba histolytica. Nature 178(4533): 599
Astrup, T.; Crookston, J.; Macintyre, A. 1950: Proteolytic enzymes in blood. Acta Physiologica Scandinavica 21(2-3): 238-249
Vartio, T. 1959: Proteolytic enzymes in cerebrospinal fluid in normal and certain pathological conditions. Annales Medicinae Experimentalis et Biologiae Fenniae 37: 193-196
Devi, A. 1963: Proteolytic enzymes in human lens. Biochimica et Biophysica Acta 73: 155-158
Miller, J.M. 1956: Proteolytic enzymes in inflammation: rationale for use. Postgraduate Medicine 19(1): 16-22
Muftic, M.K. 1957: Proteolytic enzymes in otolaryngology. Indian Journal of Medical Sciences 11(12): 1015-1020
Jung, G.; Kides, E. 1959: Proteolytic enzymes in ovarian tissue. Archiv für Gynakologie 192: 151-154
Hazan, M. 1960: Proteolytic enzymes in podiatry. Journal of the American Podiatry Association 50: 207-208
Lee, E.R. 2006: Proteolytic enzymes in skeletal development: histochemical methods adapted to the study of matrix lysis during the transformation of a "cartilage model" into bone. Frontiers in Bioscience: a Journal and Virtual Library 11: 2538-2553
Woodward, A.A. 1950: Proteolytic enzymes in the eggs of the clam, Mactra solidissima. Biological Bulletin 99(2): 367
Sans Sola, L.; Barcelo, P. 1957: Proteolytic enzymes in the treatment of various rheumatic syndromes. Revista Espanola de Reumatismo y Enfermedades Osteoarticulares 7(1): 133-138
Kukulies, H. 1956: Proteolytic enzymes in therapy of suppurative rhinitis, especially in children, and in maxillary sinus empyema. Hno 5(8): 242-244
Lefevre, E. 1952: Proteolytic enzymes in urology. Journal Belge d'Urologie 21(2): 47-49
Niewiarowski, S. 1952: Proteolytic enzymes of blood serum and their inhibitors. Polski Tygodnik Lekarski 7(5-6): 146-151
Creach, P.V. 1963: Proteolytic enzymes of fish. Annales de la Nutrition et de l'Alimentation 17: A375-A471
Otto, J.; Haehnel, R. 1960: Proteolytic enzymes of human aqueous humor. Klinische Monatsblatter für Augenheilkunde und für Augenarztliche Fortbildung 137: 286-306
Paschoud, J.M.; Schmidli, B.; Keller, W. 1955: Proteolytic enzymes of normal human skin. Archiv für Klinische und Experimentelle Dermatologie 201(5): 484-494
Vartio, T. 1960: Proteolytic enzymes of synovial fluid with special reference to intra-articularly applied hydrocortisone. Annales Medicinae Experimentalis et Biologiae Fenniae 38: 94-99
Torban, M.A. 1960: Proteolytic enzymes of tetanus toxin and their significance for its stability. Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 31: 79-83
Vartio, T. 1959: Proteolytic enzymes of the pleural and peritioneal fluids in various pathological conditions. Annales Medicinae Experimentalis et Biologiae Fenniae 37: 189-192
Pantlitschko, M.; Stattmann, K. 1955: Proteolytic enzymes of white blood corpuscles. Biochemische Zeitschrift 326(4): 252-259
Greuer, W.; Hess, E.; Rosteck, I. 1956: Proteolytic enzymes originating from tissues and their significance. Arzneimittel-Forschung 6(5): 269-275
Grob, D. 1949: Proteolytic enzymes; further studies on protein, polypeptide, and other inhibitors of serum proteinase, leucoproteinase, trypsin, and papain. Journal of General Physiology 33(2): 103-124
Miglietta, M. 1950: Proteolytic ferments in coccal pus and antiproteolytic action of blood serum. Rivista di Chirurgia E Medicina 2(7): 418-431
Benzing, H. 1954: Proteolytic ferments in the treatment of pleural empyema. Die Medizinische 31-32: 1062-1064
Bresler, S.E.; Rozentsveig, N.A. 1951: Proteolytic ferments; metalloproteins. Biokhimiia 16(1): 84-94
Uitto, V.-J.; Overall, C.M.; McCulloch, C. 2003: Proteolytic host cell enzymes in gingival crevice fluid. Periodontology 2000 31: 77-104
Crawley, J.T.B.; Lam, J.K.; Rance, J.B.; Mollica, L.R.; O'Donnell, J.S.; Lane, D.A. 2005: Proteolytic inactivation of ADAMTS13 by thrombin and plasmin. Blood 105(3): 1085-1093
Van Vliet, K.; Blouin, V.; Agbandje-McKenna, M.; Snyder, R.O. 2006: Proteolytic mapping of the adeno-associated virus capsid. Molecular Therapy: the Journal of the American Society of Gene Therapy 14(6): 809-821
Højrup, P. 2004: Proteolytic peptide mapping. Methods in Molecular Biology 251: 227-244
Yue, S.L. 1993: Proteolytic phenomenon in enamel caries. Shanghai Kou Qiang Yi Xue 2(3): 156-159
Likholat, E.A.; Anan'eva, T.V. 2005: Proteolytic processes in lung tissue of rat posterity after whole-body chronic irradiation with low doses. Radiatsionnaia Biologiia Radioecologiia 45(1): 51-55
Vergote, D.; Butler, G.S.; Ooms, M.; Cox, J.H.; Silva, C.; Hollenberg, M.D.; Jhamandas, J.H.; Overall, C.M.; Power, C. 2006: Proteolytic processing of SDF-1alpha reveals a change in receptor specificity mediating HIV-associated neurodegeneration. Proceedings of the National Academy of Sciences of the United States of America 103(50): 19182-19187
Roh, M.; Paterson, A.J.; Liu, K.; McAndrew, J.; Chin, E.; Kudlow, J.E. 2005: Proteolytic processing of TGFalpha redirects its mitogenic activity: the membrane-anchored form is autocrine, the secreted form is paracrine. Biochimica et Biophysica Acta 1743(3): 231-242
Robinson, J.J. 2006: Proteolytic processing of a sea urchin, ECM-localized protein into lower mol mass species possessing collagen-cleavage activity. Journal of Cellular Biochemistry 99(3): 816-823
Baudoin, C.; Fantin, L.; Meneguzzi, G. 2005: Proteolytic processing of the laminin alpha3 G domain mediates assembly of hemidesmosomes but has no role on keratinocyte migration. Journal of Investigative Dermatology 125(5): 883-888
Kornalik, F. 1962: Proteolytic properties of some snake venoms in their relation to the 3d and 4th phases of blood coagulation. Casopis Lekaru Ceskych 101: 759-762
Beaufort, N.; Leduc, D.; Rousselle, J.-C.; Magdolen, V.; Luther, T.; Namane, A.; Chignard, M.; Pidard, D. 2004: Proteolytic regulation of the urokinase receptor/CD87 on monocytic cells by neutrophil elastase and cathepsin G. Journal of Immunology 172(1): 540-549
Younus, H.; Schöps, R.; Lerchner, A.; Rücknagel, K.P.; Schierhorn, A.; Saleemuddin, M.; Ulbrich-Hofmann, R. 2003: Proteolytic sensitivity of a recombinant phospholipase D from cabbage: identification of loop regions and conformational changes. Journal of Protein Chemistry 22(6): 499-508
Kuhn, S.J.; Finch, S.K.; Hallahan, D.E.; Giorgio, T.D. 2006: Proteolytic surface functionalization enhances in vitro magnetic nanoparticle mobility through extracellular matrix. Nano Letters 6(2): 306-312
Piechaud, D.; Piechaud, M.; Second, L. 1956: Proteolytic types of Moraxella lwoffi and Moraxella glucidolytica (Bacterium anitratum). Annales de l'Institut Pasteur 90(4): 517-522
Skrzydlewska, E.; Sulkowska, M.; Koda, M.; Sulkowski, S. 2005: Proteolytic-antiproteolytic balance and its regulation in carcinogenesis. World Journal of Gastroenterology 11(9): 1251-1266
Garcia, M.; Peruzzini, V. 1960: Proteolytic-enzyme and antibiotic therapy of decubitus ulcers in patients with spinal cord injuries. Minerva Ortopedica 11: 470-472
Pike, I. 2003: Proteome Sciences plc. Pharmacogenomics 4(5): 669-675
Tao, F.; Smejkal, G. 2006: Proteome Society meeting. October 19, 2005, MA, USA. Expert review of proteomics 3(1): 7-8
Strittmatter, E.F.; Ferguson, P.L.; Tang, K.; Smith, R.D. 2003: Proteome analyses using accurate mass and elution time peptide tags with capillary LC time-of-flight mass spectrometry. Journal of the American Society for Mass Spectrometry 14(9): 980-991
Wang, X.; Liang, W.-J.; Zhu, Z.-Y.; Yang, M.-T.; Zeng, Y.-X. 2004: Proteome analysis for identification of tumor-associated biomarkers in breast cancer. Ai Zheng 23(11 Suppl): 1577-1581
Pastorelli, R.; Carpi, D.; Airoldi, L.; Chiabrando, C.; Bagnati, R.; Fanelli, R.; Moverare, S.; Ohlsson, C. 2005: Proteome analysis for the identification of in vivo estrogen-regulated proteins in bone. Proteomics 5(18): 4936-4945
Fels, L.üd.M.; Buschmann, T.; Meuer, J.ör.; Reymond, M.A.; Lamer, S.; Röcken, C.; Ebert, M.P.A. 2003: Proteome analysis for the identification of tumor-associated biomarkers in gastrointestinal cancer. Digestive Diseases 21(4): 292-298
Jalili, P.R.; Gheyi, T.; Dass, C. 2004: Proteome analysis in bovine adrenal medulla using matrix-assisted laser desorption/ionization mass spectrometry. Rapid Communications in Mass Spectrometry: Rcm 18(8): 914-916
Shin, J.-H.; London, J.; Le Pecheur, M.; Weitzdoerfer, R.; Hoeger, H.; Lubec, G. 2005: Proteome analysis in hippocampus of mice overexpressing human Cu/Zn-superoxide dismutase 1. Neurochemistry International 46(8): 641-653
Jalili, P.R.; Dass, C. 2004: Proteome analysis in the bovine adrenal medulla using liquid chromatography with tandem mass spectrometry. Rapid Communications in Mass Spectrometry: Rcm 18(17): 1877-1884
Joubert-Caron, R.; Caron, M. 2005: Proteome analysis in the study of lymphoma cells. Mass Spectrometry Reviews 24(4): 455-468
Bunai, K.; Yamane, K. 2004: Proteome analysis of Bacillus subtilis. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 49(7 Suppl): 1073-1074
Yoon, H.; Lim, S.; Heu, S.; Choi, S.; Ryu, S. 2003: Proteome analysis of Salmonella enterica serovar Typhimurium fis mutant. Fems Microbiology Letters 226(2): 391-396
Wang, W.; Hollmann, R.; Fürch, T.; Nimtz, M.; Malten, M.; Jahn, D.; Deckwer, W.-D. 2005: Proteome analysis of a recombinant Bacillus megaterium strain during heterologous production of a glucosyltransferase. Proteome Science 3: 4
Kabir, M.M.; Shimizu, K. 2001: Proteome analysis of a temperature-inducible recombinant Escherichia coli for poly-beta-hydroxybutyrate production. Journal of Bioscience and Bioengineering 92(3): 277-284
Li, R.; Liu, X.-L.; Du, Q.-F.; Zhang, S.; Luo, R.-C.; Zhou, S.-Y. 2004: Proteome analysis of apoptotic K562 cells induced by harringtonine. Zhonghua Xue Ye Xue Za Zhi 25(6): 323-327
Thiede, B.; Rudel, T. 2004: Proteome analysis of apoptotic cells. Mass Spectrometry Reviews 23(5): 333-349
Ueda, K. 2005: Proteome analysis of autoantibodies in sera of patients with cancer. Rinsho Byori. Japanese Journal of Clinical Pathology 53(5): 437-445
Roh, G.S.; Shin, Y.; Seo, S.-W.; Yoon, B.R.; Yeo, S.; Park, S.J.; Cho, J.W.; Kwack, K. 2004: Proteome analysis of differential protein expression in allergen-induced asthmatic mice lung after dexamethasone treatment. Proteomics 4(11): 3318-3327
Jia, X.; Hollung, K.; Therkildsen, M.; Hildrum, K.I.; Bendixen, E.øk. 2006: Proteome analysis of early post-mortem changes in two bovine muscle types: M. longissimus dorsi and M. semitendinosis. Proteomics 6(3): 936-944
Chen, J.; Kähne, T.; Röcken, C.; Götze, T.; Yu, J.; Sung, J.J.Y.; Chen, M.; Hu, P.; Malfertheiner, P.; Ebert, M.P.A. 2004: Proteome analysis of gastric cancer metastasis by two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization-mass spectrometry for identification of metastasis-related proteins. Journal of Proteome Research 3(5): 1009-1016
Miura, Y.; Kano, M.; Toda, T.; Urano, S.; Suzuki, S. 2003: Proteome analysis of glial cells treated by radiation or hydroperoxide. Uchu Seibutsu Kagaku 17(3): 249-250
Fang, C.; Yi, Z.; Liu, F.; Lan, S.; Wang, J.; Lu, H.; Yang, P.; Yuan, Z. 2006: Proteome analysis of human liver carcinoma Huh7 cells harboring hepatitis C virus subgenomic replicon. Proteomics 6(2): 519-527
Michel, P.E.; Crettaz, D.; Morier, P.; Heller, M.; Gallot, D.; Tissot, J.-D.; Reymond, F.éd.ér.; Rossier, J.S. 2006: Proteome analysis of human plasma and amniotic fluid by Off-Gel isoelectric focusing followed by nano-LC-MS/MS. Electrophoresis 27(5-6): 1169-1181
Wang, Y.; Rudnick, P.A.; Evans, E.L.; Li, J.; Zhuang, Z.; Devoe, D.L.; Lee, C.S.; Balgley, B.M. 2005: Proteome analysis of microdissected tumor tissue using a capillary isoelectric focusing-based multidimensional separation platform coupled with ESI-tandem MS. Analytical Chemistry 77(20): 6549-6556
Obermeyer, N.; Janson, N.; Bergmann, J.; Buck, F.; Ito, W.D. 2003: Proteome analysis of migrating versus nonmigrating rat heart endothelial cells reveals distinct expression patterns. Endothelium: Journal of Endothelial Cell Research 10(3): 167-178
Buerke, M.; Schwertz, Hörg.; Längin, T.; Buerke, U.; Prondzinsky, R.; Platsch, H.; Richert, J.; Bomm, S.; Schmidt, M.; Hillen, H.; Lindemann, S.; Blaschke, G.; Müller-Werdan, U.; Werdan, K. 2006: Proteome analysis of myocardial tissue following ischemia and reperfusion--effects of complement inhibition. Biochimica et Biophysica Acta 1764(10): 1536-1545
Wang, Z.-h.; Yu, D.; Zheng, J.; Chen, Y. 2005: Proteome analysis of nuclear matrix proteins during arsenic trioxide induced apoptosis in K562 cells. Beijing da Xue Xue Bao. Yi Xue Ban 37(2): 163-166
Veenstra, T.D. 2003: Proteome analysis of posttranslational modifications. Advances in Protein Chemistry 65: 161-194
Shin, J.-S.; Lee, J.-J.; Lee, E.-J.; Kim, Y.-H.; Chae, K.-S.; Kim, C.-W. 2005: Proteome analysis of rat pancreas induced by pancreatectomy. Biochimica et Biophysica Acta 1749(1): 23-32
Walther, R.; Balabanov, S.; Junker, H.; Scharf, C.; Zimmermann, U. 2004: Proteome analysis of renal cell carcinoma to develop new strategies in diagnosis and therapy. International Journal of Clinical Pharmacology and Therapeutics 42(11): 635-636
Komatsu, S.; Konishi, H. 2005: Proteome analysis of rice root proteins regulated by gibberellin. Genomics Proteomics and Bioinformatics 3(3): 132-142
Oofusa, K.; Yamagata, A.; Yoshizato, K. 2004: Proteome analysis of transformed cells and transgenic animals. Seikagaku. Journal of Japanese Biochemical Society 76(10): 1283-1288
Pluder, F.; Mörl, K.; Beck-Sickinger, A.G. 2006: Proteome analysis to study signal transduction of G protein-coupled receptors. Pharmacology and Therapeutics 112(1): 1-11
Maeda, M.; Mori, H.; Wada, C. 2003: Proteome analysis using MALDI-TOF MS. Seikagaku. Journal of Japanese Biochemical Society 75(5): 401-406
Löhr, J.M.; Faissner, R.; Findeisen, P.; Neumaier, M. 2006: Proteome analysis--basis for individualized pancreatic carcinoma therapy?. Der Internist 47(Suppl 1): S40-S48
Tan, Y.; Lv, Z.-p.; Zhang, X.-f. 2004: Proteome and its application in liver disease research. Zhonghua Gan Zang Bing Za Zhi 12(11): 700-702
Yu, Z.-y.; Du, J. 2004: Proteome and study on the essential of TCM syndromes. Zhongguo Zhong Xi Yi Jie he Za Zhi Zhongguo Zhongxiyi Jiehe Zazhi 24(9): 844-846
Criel, B.; Hausman, F.; Oufir, M.; Swennen, R.; Panis, B.; Renaut, J. 2006: Proteome and sugar analysis of abiotic stress underlying cryopreservation in potato. Communications in Agricultural and Applied Biological Sciences 71(1): 3-6
Porquet, D. 2003: Proteome and transcriptome. Transfusion Clinique et Biologique: Journal de la Societe Francaise de Transfusion Sanguine 10(3): 214-216
Sato, A.; Miyazaki, E.; Satake, A.; Hiramoto, A.; Hiraoka, O.; Miyake, T.; Kim, H.-S.; Wataya, Y. 2006: Proteome and transcriptome analysis of 5-fluoro-2'-deoxyuridine-induced cell death mechanisms. Nucleic Acids Symposium Series 50: 101-102
Kung, L.A. 2006: Proteome chips: a future perspective. Expert Review of Proteomics 3(6): 565-567
Toda, T.; Morisawa, H. 2004: Proteome database. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 49(11 Suppl): 1886-1892
Zhao, B.; Yeo, C.C.; Poh, C.L. 2005: Proteome investigation of the global regulatory role of sigma 54 in response to gentisate induction in Pseudomonas alcaligenes NCIMB 9867. Proteomics 5(7): 1868-1876
Herrmann, R.; Ruppert, T. 2006: Proteome of Mycoplasma pneumoniae. Methods of Biochemical Analysis 49: 39-56
Armandola, E.A. 2003: Proteome profiling in body fluids and in cancer cell signaling. Medgenmed: Medscape General Medicine 5(2): 18
Fröhlich, T.; Arnold, G.J. 2006: Proteome research based on modern liquid chromatography--tandem mass spectrometry: separation, identification and quantification. Journal of Neural Transmission 113(8): 973-994
An, P.; Yu, B.; Li, S.-Y.; Zhang, Y.-N.; Cai, H.-Y. 2004: Proteome study of colorectal cancer genesis and hepatic metastasis. Zhonghua Wai Ke Za Zhi 42(11): 668-671
Inoue, Y.; Ikeda, M.; Shimizu, T. 2004: Proteome-wide classification and identification of mammalian-type GPCRs by binary topology pattern. Computational Biology and Chemistry 28(1): 39-49
Usui, K. 2004: Proteome; protein resource. Tanpakushitsu Kakusan Koso. Protein Nucleic Acid Enzyme 49(17 Suppl): 2635-2641
Dowsey, A.W.; Dunn, M.J.; Yang, G.-Z. 2004: ProteomeGRID: towards a high-throughput proteomics pipeline through opportunistic cluster image computing for two-dimensional gel electrophoresis. Proteomics 4(12): 3800-3812
Ohta, M.; Fujinami, A.; Oishi, K.; Kobayashi, N.; Ohnishi, K.; Ohkura, N. 2019: Ashitaba (Angelica Keiskei) Exudate Prevents Increases in Plasminogen Activator Inhibitor-1 Induced by Obesity in Tsumura Suzuki Obese Diabetic Mice. Journal of Dietary Supplements 16(3): 331-344
Buhimschi, I.A.; Buhimschi, C.S.; Christner, R.; Norwitz, E.; Weiner, C.P. 2004: Proteomic Profiling and Intra-amniotic Infection. JAMA 292(19): 2338; Author Reply 2338-9
Comuzzi, B.; Sadar, M.D. 2006: Proteomic analyses to identify novel therapeutic targets for the treatment of advanced prostate cancer. Cellscience 3(1): 61-81
Di Quinzio, M.K.W.; Oliva, K.; Holdsworth, S.J.; Ayhan, M.; Walker, S.P.; Rice, G.E.; Georgiou, H.M.; Permezel, M. 2007: Proteomic analysis and characterisation of human cervico-vaginal fluid proteins. Australian and New Zealand Journal of Obstetrics and Gynaecology 47(1): 9-15
Choi, S.-L.; Choi, Y.-S.; Kim, Y.-K.; Sung, N.-D.; Kho, C.-W.; Park, B.-C.; Kim, E.-M.; Lee, J.-H.; Kim, K.-M.; Kim, M.-Y.; Myung, P.-K. 2006: Proteomic analysis and the antimetastatic effect of N-(4-methyl)phenyl-O-(4-methoxy) phenyl-thionocarbamate-induced apoptosis in human melanoma SK-MEL-28 cells. Archives of Pharmacal Research 29(3): 224-234
Ballot, E.; Marcelo, P.; Labas, V.; Doan, S.; Zamfir, O.; Chaumeil, C.; Vinh, J.; Batellier, L. 2004: Proteomic analysis associating two-dimensional electrophoresis and mass spectrometry to identify lacrimal proteins: a case study. Journal Francais d'Ophtalmologie 27(10): 1141-1145
Florens, L.; Washburn, M.P. 2006: Proteomic analysis by multidimensional protein identification technology. Methods in Molecular Biology 328: 159-175
Zhou, M.; Yu, L.-R. 2003: Proteomic analysis by two-dimensional polyacrylamide gel electrophoresis. Advances in Protein Chemistry 65: 57-84
Ma, Z.-C.; Gao, Y.; Wang, J.; Zhang, X.-M.; Wang, S.-Q. 2006: Proteomic analysis effects of ginsenoside Rg1 on human umbilical vein endothelial cells stimulated by tumor necrosis factor-alpha. Life Sciences 79(2): 175-181
Stevens, E.V.; Liotta, L.A.; Kohn, E.C. 2003: Proteomic analysis for early detection of ovarian cancer: a realistic approach?. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 13(Suppl 2): 133-139
Posadas, E.M.; Simpkins, F.; Liotta, L.A.; MacDonald, C.; Kohn, E.C. 2005: Proteomic analysis for the early detection and rational treatment of cancer--realistic hope?. Annals of Oncology: Official Journal of the European Society for Medical Oncology 16(1): 16-22
García-Foncillas, J.ús.; Bandrés, E.; Zárate, R.; Remírez, N. 2006: Proteomic analysis in cancer research: potential application in clinical use. Clinical and Translational Oncology: Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 8(4): 250-261
Perluigi, M.; Fai Poon, H.; Hensley, K.; Pierce, W.M.; Klein, J.B.; Calabrese, V.; De Marco, C.; Butterfield, D.A. 2005: Proteomic analysis of 4-hydroxy-2-nonenal-modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis. Free Radical Biology and Medicine 38(7): 960-968
Zhang, C.; Wei, J.; Zheng, Z.; Ying, N.; Sheng, D.; Hua, Y. 2005: Proteomic analysis of Deinococcus radiodurans recovering from gamma-irradiation. Proteomics 5(1): 138-143
Qian, J.-J.; Ying, W.-T.; Sun, G.-J.; Song, Y.; Liu, B.; Dong, Y.; Qian, X.-H.; Sun, Z.-X. 2006: Proteomic analysis of G2/M arrest of HL-60 cells induced by MG132. Ai Zheng 25(5): 533-537
Malorni, L.; Cacace, G.; Cuccurullo, M.; Pocsfalvi, G.; Chambery, A.; Farina, A.; Di Maro, A.; Parente, A.; Malorni, A. 2006: Proteomic analysis of MCF-7 breast cancer cell line exposed to mitogenic concentration of 17beta-estradiol. Proteomics 6(22): 5973-5982
Vaughan, T.E.; Skipp, P.J.; O'Connor, C.D.; Hudson, M.J.; Vipond, R.; Elmore, M.J.; Gorringe, A.R. 2006: Proteomic analysis of Neisseria lactamica and N eisseria meningitidis outer membrane vesicle vaccine antigens. Vaccine 24(25): 5277-5293
Guina, T.; Wu, M.; Miller, S.I.; Purvine, S.O.; Yi, E.C.; Eng, J.; Goodlett, D.R.; Aebersold, R.; Ernst, R.K.; Lee, K.A. 2003: Proteomic analysis of Pseudomonas aeruginosa grown under magnesium limitation. Journal of the American Society for Mass Spectrometry 14(7): 742-751
Chao, C.C.; Chelius, D.; Zhang, T.; Mutumanje, E.; Ching, W.M. 2005: Proteomic analysis of Rickettsia prowazekii. Annals of the new York Academy of Sciences 1063: 87-89
Vona-Davis, L.; Vincent, T.; Zulfiqar, S.; Jackson, B.; Riggs, D.; McFadden, D.W. 2004: Proteomic analysis of SEG-1 human Barrett's-associated esophageal adenocarcinoma cells treated with keyhole limpet hemocyanin. Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract 8(8): 1018-1023
Guo, D.; Han, J.; Adam, B.-L.; Colburn, N.H.; Wang, M.-H.; Dong, Z.; Eizirik, D.L.; She, J.-X.; Wang, C.-Y. 2005: Proteomic analysis of SUMO4 substrates in HEK293 cells under serum starvation-induced stress. Biochemical and Biophysical Research Communications 337(4): 1308-1318
Martí, S.; Sánchez-Céspedes, J.; Oliveira, E.; Bellido, D.; Giralt, E.; Vila, J. 2006: Proteomic analysis of a fraction enriched in cell envelope proteins of Acinetobacter baumannii. Proteomics 6(Suppl 1): S82-S87
Vipond, C.; Suker, J.; Jones, C.; Tang, C.; Feavers, I.M.; Wheeler, J.X. 2006: Proteomic analysis of a meningococcal outer membrane vesicle vaccine prepared from the group B strain NZ98/254. Proteomics 6(11): 3400-3413
López-Pedrera, C.; Villalba, J.é M.; Siendones, E.; Barbarroja, N.; Gómez-Díaz, C.; Rodríguez-Ariza, A.; Buendía, P.; Torres, A.; Velasco, F. 2006: Proteomic analysis of acute myeloid leukemia: Identification of potential early biomarkers and therapeutic targets. Proteomics 6(Suppl 1): S293-S299
Zada, A.A.Peer.; Geletu, M.H.; Pulikkan, J.A.; Müller-Tidow, C.; Reddy, V.A.; Christopeit, M.; Hiddemann, W.D.; Behre, H.M.; Tenen, D.G.; Behre, G. 2006: Proteomic analysis of acute promyelocytic leukemia: PML-RARalpha leads to decreased phosphorylation of OP18 at serine 63. Proteomics 6(21): 5705-5719
Havlasová, J.; Hernychová, L.; Brychta, M.; Hubálek, M.; Lenco, J.; Larsson, P.är.; Lundqvist, M.; Forsman, M.; Krocová, Z.; Stulík, J.; Macela, A. 2005: Proteomic analysis of anti-Francisella tularensis LVS antibody response in murine model of tularemia. Proteomics 5(8): 2090-2103
Gulmann, C.; Espina, V.; Petricoin, E.; Longo, D.L.; Santi, M.; Knutsen, T.; Raffeld, M.; Jaffe, E.S.; Liotta, L.A.; Feldman, A.L. 2005: Proteomic analysis of apoptotic pathways reveals prognostic factors in follicular lymphoma. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 11(16): 5847-5855
An, J.-Y.; Fan, Z.-M.; Zhuang, Z.-H.; Qin, Y.-R.; Gao, S.-S.; Li, J.-L.; Wang, L.-D. 2004: Proteomic analysis of blood level of proteins before and after operation in patients with esophageal squamous cell carcinoma at high-incidence area in Henan Province. World Journal of Gastroenterology 10(22): 3365-3368
Cook, L.A.; Schey, K.L.; Wilcox, M.D.; Dingus, J.; Ettling, R.; Nelson, T.; Knapp, D.R.; Hildebrandt, J.D. 2006: Proteomic analysis of bovine brain G protein gamma subunit processing heterogeneity. Molecular and Cellular Proteomics: Mcp 5(4): 671-685
Yoo, B.-S.; Regnier, F.E. 2004: Proteomic analysis of carbonylated proteins in two-dimensional gel electrophoresis using avidin-fluorescein affinity staining. Electrophoresis 25(9): 1334-1341
Jin, J.-h.; Gao, Z.-h.; Yang, J.; Yu, Y.-n. 2003: Proteomic analysis of cellular responses to low concentration of N-methyl-N'-nitro-N-nitrosoguanidine in human amnion FL cells. Zhejiang da Xue Xue Bao. Yi Xue Ban 32(5): 375-379
Chen, W.G.; White, F.M. 2004: Proteomic analysis of cellular signaling. Expert Review of Proteomics 1(3): 343-354
Mader, R.M.; Schmidt, W.M.; Mitterer, G.; Gerner, C. 2005: Proteomic analysis of chemoresistance to 5-fluorouracil in colon cancer in vitro. International Journal of Clinical Pharmacology and Therapeutics 43(12): 599-600
Aivaliotis, M.; Haase, W.; Karas, M.; Tsiotis, G. 2006: Proteomic analysis of chlorosome-depleted membranes of the green sulfur bacterium Chlorobium tepidum. Proteomics 6(1): 217-232
Kim, J.Lim.; Jung, H.Hyun. 2004: Proteomic analysis of cholesteatoma. Acta Oto-Laryngologica 124(7): 783-788
Qiu, Y.; Kathariou, S.; Lubman, D.M. 2006: Proteomic analysis of cold adaptation in a Siberian permafrost bacterium--Exiguobacterium sibiricum 255-15 by two-dimensional liquid separation coupled with mass spectrometry. Proteomics 6(19): 5221-5233
Skandarajah, A.R.; Moritz, R.L.; Tjandra, J.J.; Simpson, R.J. 2005: Proteomic analysis of colorectal cancer: discovering novel biomarkers. Expert Review of Proteomics 2(5): 681-692
Chen, W.; Ji, J.; Ru, B. 2005: Proteomic analysis of corticobasal degeneration: a case study of corticobasal degeneration at the proteome level. Journal of Neuropsychiatry and Clinical Neurosciences 17(3): 364-371
Blonder, J.; Hale, M.L.; Lucas, D.A.; Schaefer, C.F.; Yu, L.-R.; Conrads, T.P.; Issaq, H.J.; Stiles, B.G.; Veenstra, T.D. 2004: Proteomic analysis of detergent-resistant membrane rafts. Electrophoresis 25(9): 1307-1318
Insenser, M.ía.; Nombela, C.és.; Molero, G.; Gil, C. 2006: Proteomic analysis of detergent-resistant membranes from Candida albicans. Proteomics 6(Suppl 1): S74-S81
Yuan, Q.; An, J.; Liu, D.-G.; Sun, L.; Ge, Y.-Z.; Huang, Y.-L.; Xu, G.-J.; Zhao, F.-K. 2004: Proteomic analysis of differential protein expression in a human hepatoma revertant cell line by using an improved two-dimensional electrophoresis procedure combined with matrix assisted laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis 25(7-8): 1160-1168
Ying-Tao, Z.; Yi-Ping, G.; Lu-Sheng, S.; Yi-Li, W. 2005: Proteomic analysis of differentially expressed proteins between metastatic and non-metastatic human colorectal carcinoma cell lines. European Journal of Gastroenterology and Hepatology 17(7): 725-732
Chen, G.; Gharib, T.G.; Thomas, D.G.; Huang, C-Ching.; Misek, D.E.; Kuick, R.D.; Giordano, T.J.; Iannettoni, M.D.; Orringer, M.B.; Hanash, S.M.; Beer, D.G. 2003: Proteomic analysis of eIF-5A in lung adenocarcinomas. Proteomics 3(4): 496-504
Yang, P.-Y.; Rui, Y.-C.; Yang, P.-Y.; Yu, Y.-L. 2007: Proteomic analysis of foam cells. Methods in Molecular Biology 357: 297-305
Harvey, D.J. 2005: Proteomic analysis of glycosylation: structural determination of N- and O-linked glycans by mass spectrometry. Expert Review of Proteomics 2(1): 87-101
Gläsker, S.; Vortmeyer, A.O.; Lonser, R.R.; Lubensky, I.A.; Okamoto, H.; Xia, J.B.; Li, J.; Milne, E.; Kowalak, J.A.; Oldfield, E.H.; Zhuang, Z. 2006: Proteomic analysis of hemangioblastoma cyst fluid. Cancer Biology and Therapy 5(5): 549-553
Shastry, S.; Tyagi, N.; Hayden, M.R.; Tyagi, S.C. 2004: Proteomic analysis of homocysteine inhibition of microvascular endothelial cell angiogenesis. Cellular and Molecular Biology 50(8): 931-937
Cui, J.-W.; Wang, J.; He, K.; Jin, B.-F.; Wang, H.-X.; Li, W.; Kang, L.-H.; Hu, M.-R.; Li, H.-Y.; Yu, M.; Shen, B.-F.; Wang, G.-J.; Zhang, X.-M. 2004: Proteomic analysis of human acute leukemia cells: insight into their classification. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 10(20): 6887-6896
Krieg, R.C.; Gaisa, N.T.; Paweletz, C.P.; Knuechel, R. 2005: Proteomic analysis of human bladder tissue using SELDI approach following microdissection techniques. Methods in Molecular Biology 293: 255-267
Cowherd, S.M.; Espina, V.A.; Petricoin, E.F.; Liotta, L.A. 2004: Proteomic analysis of human breast cancer tissue with laser-capture microdissection and reverse-phase protein microarrays. Clinical Breast Cancer 5(5): 385-392
Saphire, A.C.S.; Gallay, P.A.; Bark, S.J. 2006: Proteomic analysis of human immunodeficiency virus using liquid chromatography/tandem mass spectrometry effectively distinguishes specific incorporated host proteins. Journal of Proteome Research 5(3): 530-538
Lominadze, G.; Ward, R.A.; Klein, J.B.; McLeish, K.R. 2006: Proteomic analysis of human neutrophils. Methods in Molecular Biology 332: 343-356
Yan, X.-d.; Pan, L.-y. 2006: Proteomic analysis of human ovarian cancer cell lines and their platinum-resistant clones. Zhonghua Fu Chan Ke Za Zhi 41(9): 584-587
Zhao, Y.; Zhang, W.; Kho, Y.; Zhao, Y. 2004: Proteomic analysis of integral plasma membrane proteins. Analytical Chemistry 76(7): 1817-1823
Godl, K.; Daub, H. 2004: Proteomic analysis of kinase inhibitor selectivity and function. Cell Cycle 3(4): 393-395
Van Balkom, B.W.M.; Hoffert, J.D.; Chou, C.-L.; Knepper, M.A. 2004: Proteomic analysis of long-term vasopressin action in the inner medullary collecting duct of the Brattleboro rat. American Journal of Physiology. Renal Physiology 286(2): F216-F224
Davidson, B.; Espina, V.; Steinberg, S.M.; Flørenes, V.A.; Liotta, L.A.; Kristensen, G.B.; Tropé, C.G.; Berner, A.; Kohn, E.C. 2006: Proteomic analysis of malignant ovarian cancer effusions as a tool for biologic and prognostic profiling. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 12(3 Part 1): 791-799
Ghobrial, I.M.; McCormick, D.J.; Kaufmann, S.H.; Leontovich, A.A.; Loegering, D.A.; Dai, N.T.; Krajnik, K.L.; Stenson, M.J.; Melhem, M.F.; Novak, A.J.; Ansell, S.M.; Witzig, T.E. 2005: Proteomic analysis of mantle-cell lymphoma by protein microarray. Blood 105(9): 3722-3730
Ishioka, S.-i.; Ezaka, Y.; Umemura, K.; Hayashi, T.; Endo, T.; Saito, T. 2006: Proteomic analysis of mechanisms of hypoxia-induced apoptosis in trophoblastic cells. International Journal of Medical Sciences 4(1): 36-44
Kulawiec, M.; Arnouk, H.; Desouki, M.M.; Kazim, L.; Still, I.; Singh, K.K. 2006: Proteomic analysis of mitochondria-to-nucleus retrograde response in human cancer. Cancer Biology and Therapy 5(8): 967-975
Lopez, M.F.; Melov, S.; Johnson, F.; Nagulko, N.; Golenko, E.; Kuzdzal, S.; Ackloo, S.; Mikulskis, A. 2004: Proteomic analysis of mitochondrial proteins. International Review of Neurobiology 61: 31-48
Yeom, M.; Shim, I.; Lee, H.-J.; Hahm, D.-H. 2005: Proteomic analysis of nicotine-associated protein expression in the striatum of repeated nicotine-treated rats. Biochemical and Biophysical Research Communications 326(2): 321-328
Pawlik, T.M.; Hawke, D.H.; Liu, Y.; Krishnamurthy, S.; Fritsche, H.; Hunt, K.K.; Kuerer, H.M. 2006: Proteomic analysis of nipple aspirate fluid from women with early-stage breast cancer using isotope-coded affinity tags and tandem mass spectrometry reveals differential expression of vitamin D binding protein. Bmc Cancer 6: 68
Kim, C.H.; Zou, Y.; Kim, D.H.; Kim, N.D.; Yu, B.P.; Chung, H.Y. 2006: Proteomic analysis of nitrated and 4-hydroxy-2-nonenal-modified serum proteins during aging. Journals of Gerontology. Series a Biological Sciences and Medical Sciences 61(4): 332-338
Stapels, M.D.; Cho, J.-C.; Giovannoni, S.J.; Barofsky, D.F. 2004: Proteomic analysis of novel marine bacteria using MALdi and ESi mass spectrometry. Journal of Biomolecular Techniques: Jbt 15(3): 191-198
Iwabata, H.; Yoshida, M.; Komatsu, Y. 2005: Proteomic analysis of organ-specific post-translational lysine-acetylation and -methylation in mice by use of anti-acetyllysine and -methyllysine mouse monoclonal antibodies. Proteomics 5(18): 4653-4664
Pocernich, C.B.; Poon, H.F.; Boyd-Kimball, D.; Lynn, B.C.; Nath, A.; Klein, J.B.; Butterfield, D.A. 2005: Proteomic analysis of oxidatively modified proteins induced by the mitochondrial toxin 3-nitropropionic acid in human astrocytes expressing the HIV protein tat. Brain Research. Molecular Brain Research 133(2): 299-306
Alfonso, P.; Dolado, I.; Swat, A.; Núñez, A.; Cuadrado, A.; Nebreda, A.R.; Casal, J.I. 2006: Proteomic analysis of p38alpha mitogen-activated protein kinase-regulated changes in membrane fractions of RAS-transformed fibroblasts. Proteomics 6(Suppl 1): S262-S271
Pavón, E.J.; Muñoz, P.; Lario, A.; Longobardo, V.; Carrascal, M.; Abián, J.ín.; Martin, A.B.; Arias, S.A.; Callejas-Rubio, J.é-L.; Sola, R.; Navarro-Pelayo, F.; Raya-Alvarez, E.; Ortego-Centeno, N.; Zubiaur, M.; Sancho, J. 2006: Proteomic analysis of plasma from patients with systemic lupus erythematosus: increased presence of haptoglobin alpha2 polypeptide chains over the alpha1 isoforms. Proteomics 6(Suppl 1): S282-S292
Kim, C.H.; Park, D.U.; Chung, A.S.; Zou, Y.; Jung, K.J.; Sung, B.K.; Yu, B.P.; Chung, H.Y. 2004: Proteomic analysis of post-mitochondrial fractions of young and old rat kidney. Experimental Gerontology 39(8): 1155-1168
Monge, M.; Vilaseca, M.; Soto-Cerrato, V.; Montaner, B.; Giralt, E.; Pérez-Tomás, R. 2007: Proteomic analysis of prodigiosin-induced apoptosis in a breast cancer mitoxantrone-resistant (MCF-7 MR) cell line. Investigational new Drugs 25(1): 21-29
Choi, Y.P.; Kang, S.; Hong, S.; Xie, X.; Cho, N.H. 2005: Proteomic analysis of progressive factors in uterine cervical cancer. Proteomics 5(6): 1481-1493
Liu, Y.; Liu, P.; Liu, C.-h.; Hu, Y.-y.; Xu, L.-m.; Mu, Y.-p.; Du, G.-l. 2005: Proteomic analysis of proliferation and apoptosis in carbon tetrachloride induced rat liver fibrosis. Zhonghua Gan Zang Bing Za Zhi 13(8): 563-566
Pan, Y.-z.; Xiao, X.-y.; Zhao, D.; Zhang, L.; Ji, G.-y.; Li, Y.; He, D.-c.; Zhao, X.-j.; Yang, B.-x. 2005: Proteomic analysis of prostate cancer using surface enhanced laser desorption/ionization mass spectrometry. Zhonghua Yi Xue Za Zhi 85(45): 3172-3175
Perluigi, M.; Poon, H.F.; Maragos, W.; Pierce, W.M.; Klein, J.B.; Calabrese, V.; Cini, C.; De Marco, C.; Butterfield, D.A. 2005: Proteomic analysis of protein expression and oxidative modification in r6/2 transgenic mice: a model of Huntington disease. Molecular and Cellular Proteomics: Mcp 4(12): 1849-1861
Lexander, H.; Palmberg, C.; Auer, G.; Hellström, M.; Franzén, B.; Jörnvall, H.; Egevad, L. 2005: Proteomic analysis of protein expression in prostate cancer. Analytical and Quantitative Cytology and Histology 27(5): 263-272
Pinet, F.; Poirier, F.; Fuchs, S.éb.; Tharaux, P.-L.; Caron, M.; Corvol, P.; Michel, J.-B.; Joubert-Caron, R. 2004: Proteomic analysis of proteins involved in the renal phenotype in renovascular hypertension. Therapie 59(1): 13-20
Qin, H.; Liu, T.; Yang, J.-l.; Yang, H.-s.; Meng, W.-t.; Kan, B.; Wei, Y.-q.; Zhao, X.; Liu, B.; Song, X. 2006: Proteomic analysis of proteins related to retinoid acid resistance. Sichuan da Xue Xue Bao. Yi Xue Ban 37(1): 133-136
Cantero, L.; Palacios, J.é M.; Ruiz-Argüeso, T.ás.; Imperial, J. 2006: Proteomic analysis of quorum sensing in Rhizobium leguminosarum biovar viciae UPM791. Proteomics 6(Suppl 1): S97-106
Li, Z.-B.; Lehar, M.; Samlan, R.; Flint, P.W. 2005: Proteomic analysis of rat laryngeal muscle following denervation. Proteomics 5(18): 4764-4776
Ishikawa, I.; Hayama, T.; Yoshida, S.; Asaka, M.; Tomosugi, N.; Watanabe, M.; Yamato, H.; Sugano, M. 2006: Proteomic analysis of rat plasma by SELDI-TOF-MS under the condition of prevention of progressive adriamycin nephropathy using oral adsorbent AST-120. Nephron. Physiology 103(3): P125-P130
Vazquez-Pianzola, P.; Urlaub, H.; Rivera-Pomar, R. 2005: Proteomic analysis of reaper 5' untranslated region-interacting factors isolated by tobramycin affinity-selection reveals a role for La antigen in reaper mRNA translation. Proteomics 5(6): 1645-1655
Thongboonkerd, V. 2005: Proteomic analysis of renal diseases: unraveling the pathophysiology and biomarker discovery. Expert Review of Proteomics 2(3): 349-366
Komatsu, S.; Abbasi, F.; Kobori, E.; Fujisawa, Y.; Kato, H.; Iwasaki, Y. 2005: Proteomic analysis of rice embryo: an approach for investigating Galpha protein-regulated proteins. Proteomics 5(15): 3932-3941
Huang, L.-J.; Chen, S.-X.; Luo, W.-J.; Jiang, H.-H.; Zhang, P.-F.; Yi, H. 2006: Proteomic analysis of secreted proteins of non-small cell lung cancer. Ai Zheng 25(11): 1361-1367
Sloane, A.J.; Lindner, R.A.; Prasad, S.S.; Sebastian, L.T.; Pedersen, S.K.; Robinson, M.; Bye, P.T.; Nielson, D.W.; Harry, J.L. 2005: Proteomic analysis of sputum from adults and children with cystic fibrosis and from control subjects. American Journal of Respiratory and Critical Care Medicine 172(11): 1416-1426
Macdonald, N.; Cumberbatch, M.; Singh, M.; Moggs, J.G.; Orphanides, G.; Dearman, R.J.; Griffiths, C.E.M.; Kimber, I. 2006: Proteomic analysis of suction blister fluid isolated from human skin. Clinical and Experimental Dermatology 31(3): 445-448
Brunner, J.ür.; Bronisch, T.; Uhr, M.; Ising, M.; Binder, E.; Holsboer, F.; Turck, C.W. 2005: Proteomic analysis of the CSF in unmedicated patients with major depressive disorder reveals alterations in suicide attempters. European Archives of Psychiatry and Clinical Neuroscience 255(6): 438-440
Cepek, L.; Brechlin, P.; Steinacker, P.; Mollenhauer, B.; Klingebiel, E.; Bibl, M.; Kretzschmar, H.A.; Wiltfang, J.; Otto, M. 2007: Proteomic analysis of the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Dementia and Geriatric Cognitive Disorders 23(1): 22-28
Jiang, L.; Lindpaintner, K.; Li, H-F.; Gu, N-F.; Langen, H.; He, L.; Fountoulakis, M. 2003: Proteomic analysis of the cerebrospinal fluid of patients with schizophrenia. Amino Acids 25(1): 49-57
Tewari, A.K.; Roy, S.; Khanna, S.; Sen, C.K. 2004: Proteomic analysis of the mammalian cell nucleus. Methods in Enzymology 381: 192-201
Fletcher, S.T.; Basketter, D.A. 2006: Proteomic analysis of the response of EpiDerm cultures to sodium lauryl sulphate. Toxicology in Vitro: An International Journal Published in Association with Bibra 20(6): 975-985
Huo, C.-M.; Zhao, B.-C.; Ge, R.-C.; Shen, Y.-Z.; Huang, Z.-J. 2004: Proteomic analysis of the salt tolerance mutant of wheat under salt stress. Yi Chuan Xue Bao 31(12): 1408-1414
Braschi, S.; Borges, W.C.; Wilson, R.A. 2006: Proteomic analysis of the schistosome tegument and its surface membranes. Memorias do Instituto Oswaldo Cruz 101(Suppl 1): 205-212
Fearnley, I.M.; Carroll, J.; Walker, J.E. 2007: Proteomic analysis of the subunit composition of complex i (NADH:ubiquinone oxidoreductase) from bovine heart mitochondria. Methods in Molecular Biology 357: 103-125
Pérez-Sánchez, R.; Ramajo-Hernández, A.; Ramajo-Martín, V.; Oleaga, A. 2006: Proteomic analysis of the tegument and excretory-secretory products of adult Schistosoma bovis worms. Proteomics 6(Suppl 1): S226-S236
Barona, J.; Batista, C.V.F.; Zamudio, F.Z.; Gomez-Lagunas, F.; Wanke, E.; Otero, R.; Possani, L.D. 2006: Proteomic analysis of the venom and characterization of toxins specific for Na+ - and K+ -channels from the Colombian scorpion Tityus pachyurus. Biochimica et Biophysica Acta 1764(1): 76-84
Casado-Vela, J.; Sellés, S.; Martínez, R.B. 2006: Proteomic analysis of tobacco mosaic virus-infected tomato (Lycopersicon esculentum M.) fruits and detection of viral coat protein. Proteomics 6(Suppl 1): S196-S206
Peng, J.; Cheng, D. 2005: Proteomic analysis of ubiquitin conjugates in yeast. Methods in Enzymology 399: 367-381
Jain, S.; Rajput, A.; Kumar, Y.; Uppuluri, N.; Arvind, A.S.; Tatu, U. 2005: Proteomic analysis of urinary protein markers for accurate prediction of diabetic kidney disorder. Journal of the Association of Physicians of India 53: 513-520
Pshezhetsky, A.V. 2007: Proteomic analysis of vascular smooth muscle cells treated with ouabain. Methods in Molecular Biology 357: 253-269
Song, H.-y.; Liu, Y.-k.; Cui, J.-f.; Zhang, L.-j.; Dai, Z.; Feng, J.-t.; Feng, J.-x.; Shen, H.-l.; Yang, P.-y. 2005: Proteomic analysis on metastasis-associated proteins of hepatocellular carcinoma tissues. Zhonghua Gan Zang Bing Za Zhi 13(5): 331-334
Verrills, N.M.; Liem, N.L.; Liaw, T.Y.E.; Hood, B.D.; Lock, R.B.; Kavallaris, M. 2006: Proteomic analysis reveals a novel role for the actin cytoskeleton in vincristine resistant childhood leukemia--an in vivo study. Proteomics 6(5): 1681-1694
Casey, T.M.; Arthur, P.G.; Bogoyevitch, M.A. 2005: Proteomic analysis reveals different protein changes during endothelin-1- or leukemic inhibitory factor-induced hypertrophy of cardiomyocytes in vitro. Molecular and Cellular Proteomics: Mcp 4(5): 651-661
Kuncewicz, T.; Sheta, E.A.; Goldknopf, I.L.; Kone, B.C. 2004: Proteomic analysis reveals novel protein targets of S-nitrosylation in mesangial cells. Contributions to Nephrology 141: 221-230
Dohke, T.; Wada, A.; Isono, T.; Fujii, M.; Yamamoto, T.; Tsutamoto, T.; Horie, M. 2006: Proteomic analysis reveals significant alternations of cardiac small heat shock protein expression in congestive heart failure. Journal of Cardiac Failure 12(1): 77-84
Alexander, H.; Stegner, A.L.; Wagner-Mann, C.; Du Bois, G.C.; Alexander, S.; Sauter, E.R. 2004: Proteomic analysis to identify breast cancer biomarkers in nipple aspirate fluid. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 10(22): 7500-7510
Nanduri, B.; Lawrence, M.L.; Vanguri, S.; Pechan, T.; Burgess, S.C. 2005: Proteomic analysis using an unfinished bacterial genome: the effects of subminimum inhibitory concentrations of antibiotics on Mannheimia haemolytica virulence factor expression. Proteomics 5(18): 4852-4863
Dai, J.; Shieh, C.H.; Sheng, Q.-H.; Zhou, H.; Zeng, R. 2005: Proteomic analysis with integrated multiple dimensional liquid chromatography/mass spectrometry based on elution of ion exchange column using pH steps. Analytical Chemistry 77(18): 5793-5799
Saunders, N.F.W.; Ng, C.; Raftery, M.; Guilhaus, M.; Goodchild, A.; Cavicchioli, R. 2006: Proteomic and computational analysis of secreted proteins with type i signal peptides from the Antarctic archaeon Methanococcoides burtonii. Journal of Proteome Research 5(9): 2457-2464
Wilmarth, P.A.; Taube, J.R.; Riviere, M.A.; Duncan, M.K.; David, L.L. 2004: Proteomic and sequence analysis of chicken lens crystallins reveals alternate splicing and translational forms of beta B2 and beta A2 crystallins. Investigative Ophthalmology and Visual Science 45(8): 2705-2715
Tomás-Gallardo, L.; Canosa, I.és.; Santero, E.; Camafeita, E.; Calvo, E.; López, J.A.; Floriano, B.én. 2006: Proteomic and transcriptional characterization of aromatic degradation pathways in Rhodoccocus sp. strain TFB. Proteomics 6(Suppl 1): S119-S132
Mayya, V.; K Han, D. 2006: Proteomic applications of protein quantification by isotope-dilution mass spectrometry. Expert Review of Proteomics 3(6): 597-610
Kamoun-Essghaier, S.; Guizani, I.; Strub, J.M.; Van Dorsselaer, A.; Mabrouk, K.; Ouelhazi, L.; Dellagi, K. 2005: Proteomic approach for characterization of immunodominant membrane-associated 30- to 36-kiloDalton fraction antigens of Leishmania infantum promastigotes, reacting with sera from Mediterranean visceral leishmaniasis patients. Clinical and Diagnostic Laboratory Immunology 12(2): 310-320
Choi, Y.-W.; Tan, Y.-J.; Lim, S.G.; Hong, W.; Goh, P.-Y. 2004: Proteomic approach identifies HSP27 as an interacting partner of the hepatitis C virus NS5A protein. Biochemical and Biophysical Research Communications 318(2): 514-519
Yeo, M.; Cho, S.W.; Hahm, K.-B. 2004: Proteomic approach in gastrointestinal and liver research. Korean Journal of Gastroenterology 44(5): 239-245
Barati, M.T.; Powell, D.W.; McLeish, K.R. 2004: Proteomic approach to identification of novel kinase substrates in mesangial cells. Contributions to Nephrology 141: 231-244
Molero, L.; García-Méndez, A.; Alonso-Orgaz, S.; Carrasco, C.; Macaya, C.; López Farré, A.J. 2005: Proteomic approach to identify changes in protein expression modified by 17beta-oestradiol in bovine vascular smooth muscle cells. Clinical Science 109(5): 457-463
Zhang, G.; Wang, S. 2007: Proteomic approach to substrates related to MAPK pathway in 293T cells. Cell Biology International 31(1): 1-10
Li, X.; Pan, W.; Qiu, F.; Qiu, Z.Y. 2006: Proteomic approach to the effect of epirubicin on hepatoma cells at subcellular level. Fen Zi Xi Bao Sheng Wu Xue Bao 39(5): 407-413
Righetti, P.G.; Castagna, A.; Antonioli, P.; Cecconi, D.; Campostrini, N.; Righetti, S.C. 2005: Proteomic approaches for studying chemoresistance in cancer. Expert Review of Proteomics 2(2): 215-228
Flory, M.R.; Aebersold, R. 2003: Proteomic approaches for the identification of cell cycle-related drug targets. Progress in Cell Cycle Research 5: 167-171
Alessandro, R.; Belluco, C.; Kohn, E.C. 2005: Proteomic approaches in colon cancer: promising tools for new cancer markers and drug target discovery. Clinical Colorectal Cancer 4(6): 396-402
Soares, H.D.; Williams, S.A.; Snyder, P.J.; Gao, F.; Stiger, T.; Rohlff, C.; Herath, A.; Sunderland, T.; Putnam, K.; White, W.Frost. 2004: Proteomic approaches in drug discovery and development. International Review of Neurobiology 61: 97-126
Naaby-Hansen, S.; Warnasuriya, G.D.; Hastie, C.; Gallney, P.; Cramer, R. 2005: Proteomic approaches in the analysis of hypertension. Methods in Molecular Medicine 108: 275-296
Dobos, K.M.; Spencer, J.S.; Orme, I.M.; Belisle, J.T. 2004: Proteomic approaches to antigen discovery. Methods in Molecular Medicine 94: 3-17
Wulfkuhle, J.D.; Paweletz, C.P.; Steeg, P.S.; Petricoin, E.F.; Liotta, L. 2003: Proteomic approaches to the diagnosis, treatment, and monitoring of cancer. Advances in Experimental Medicine and Biology 532: 59-68
Hollyfield, J.G.; Salomon, R.G.; Crabb, J.W. 2003: Proteomic approaches to understanding age-related macular degeneration. Advances in Experimental Medicine and Biology 533: 83-89
Buhimschi, I.A.; Christner, R.; Buhimschi, C.S. 2005: Proteomic biomarker analysis of amniotic fluid for identification of intra-amniotic inflammation. Bjog: An International Journal of Obstetrics and Gynaecology 112(2): 173-181
Zhang, J.; Goodlett, D.R.; Montine, T.J. 2005: Proteomic biomarker discovery in cerebrospinal fluid for neurodegenerative diseases. Journal of Alzheimer's Disease: Jad 8(4): 377-386
Rajapakse, J.C.; Duan, K.-B.; Yeo, W.K. 2005: Proteomic cancer classification with mass spectrometry data. American Journal of Pharmacogenomics: Genomics-Related Research in Drug Development and Clinical Practice 5(5): 281-292
Kiri, A.N.; Tran, H.-C.; Drahos, K.L.; Lan, W.; McRorie, D.K.; Horn, M.J. 2005: Proteomic changes in bovine heart mitochondria with age: using a novel technique for organelle separation and enrichment. Journal of Biomolecular Techniques: Jbt 16(4): 371-379
Trabalzini, L.; Paffetti, A.; Ferro, E.; Scaloni, A.; Talamo, F.; Millucci, L.; Martelli, P.; Santucci, A. 2003: Proteomic characterization of a wild-type wine strain of Saccharomyces cerevisiae. Italian Journal of Biochemistry 52(4): 145-153
Nguyen, H.T.T.; Amine, A.B.; Lafitte, D.; Waheed, A.A.; Nicoletti, C.; Villard, C.; Létisse, M.; Deyris, V.ér.; Rozière, M.; Tchiakpe, L.éo.; Danielle, C.-D.; Comeau, L.; Hiol, A. 2006: Proteomic characterization of lipid rafts markers from the rat intestinal brush border. Biochemical and Biophysical Research Communications 342(1): 236-244
Huang, C.-M.; Xu, H.; Wang, C.-C.; Elmets, C.A. 2005: Proteomic characterization of skin and epidermis in response to environmental agents. Expert Review of Proteomics 2(5): 809-820
Yamaguchi, K.; Beligni, Mía.Verónica.; Prieto, S.; Haynes, P.A.; McDonald, W.Hayes.; Yates, J.R.; Mayfield, S.P. 2003: Proteomic characterization of the Chlamydomonas reinhardtii chloroplast ribosome. Identification of proteins unique to th e70 S ribosome. Journal of Biological Chemistry 278(36): 33774-33785
Wang, Y.; He, Q.-Y.; Che, C.-M.; Chiu, J.-F. 2006: Proteomic characterization of the cytotoxic mechanism of gold (III) porphyrin 1a, a potential anticancer drug. Proteomics 6(1): 131-142
Celis, J.E.; Gromov, P.; Cabezón, T.; Moreira, Jé.M.A.; Ambartsumian, N.; Sandelin, K.; Rank, F.; Gromova, I. 2004: Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery. Molecular and Cellular Proteomics: Mcp 3(4): 327-344
Wang, L.-n.; Yang, G.-f.; He, S.-z.; Ji, J.-g.; Zhu, M.-w.; Wang, Q.-s. 2005: Proteomic comparison between human cerebellums and frontal lobes. Zhonghua Nei Ke Za Zhi 44(4): 254-257
Okamoto, H.; Li, J.; Gläsker, S.; Vortmeyer, A.O.; Jaffe, H.; Robison, R.A.; Bogler, O.; Mikkelsen, T.; Lubensky, I.A.; Oldfield, E.H.; Zhuang, Z. 2007: Proteomic comparison of oligodendrogliomas with and without 1pLOH. Cancer Biology and Therapy 6(3): 391-396
Li, C.; Zhan, X.; Li, M.; Wu, X.; Li, F.; Li, J.; Xiao, Z.; Chen, Z.; Feng, X.; Chen, P.; Xie, J.; Liang, S. 2003: Proteomic comparison of two-dimensional gel electrophoresis profiles from human lung squamous carcinoma and normal bronchial epithelial tissues. Genomics Proteomics and Bioinformatics 1(1): 58-67
Hartman, N.T.; Sicilia, F.; Lilley, K.S.; Dupree, P. 2007: Proteomic complex detection using sedimentation. Analytical Chemistry 79(5): 2078-2083
Orchard, S.; Jones, P.; Taylor, C.; Zhu, W.; Julian, R.K.; Hermjakob, H.; Apweiler, R. 2007: Proteomic data exchange and storage: the need for common standards and public repositories. Methods in Molecular Biology 367: 261-270
Gärdén, P.; Alm, R. 2007: Proteomic data exchange and storage: using Proteios. Methods in Molecular Biology 367: 241-259
Lucchese, A.; Mittelman, A.; Tessitore, L.; Serpico, R.; Sinha, A.A.; Kanduc, D. 2006: Proteomic definition of a desmoglein linear determinant common to Pemphigus vulgaris and Pemphigus foliaceous. Journal of Translational Medicine 4: 37
Woltjer, R.L.; Cimino, P.J.; Boutté, A.M.; Schantz, A.M.; Montine, K.S.; Larson, E.B.; Bird, T.; Quinn, J.F.; Zhang, J.; Montine, T.J. 2005: Proteomic determination of widespread detergent-insolubility including Abeta but not tau early in the pathogenesis of Alzheimer's disease. Faseb Journal: Official Publication of the Federation of American Societies for Experimental Biology 19(13): 1923-1925
Schilling, O.; Overall, C.M. 2007: Proteomic discovery of protease substrates. Current Opinion in Chemical Biology 11(1): 36-45
Beck, J.L.; Urathamakul, T.; Watt, S.J.; Sheil, M.M.; Schaeffer, P.M.; Dixon, N.E. 2006: Proteomic dissection of DNA polymerization. Expert Review of Proteomics 3(2): 197-211
Zucchi, I.; Dulbecco, R. 2002: Proteomic dissection of dome formation in a mammary cell line. Journal of Mammary Gland Biology and Neoplasia 7(4): 373-384
Alm, H.; Scholz, B.; Fischer, C.; Kultima, K.; Viberg, H.; Eriksson, P.; Dencker, L.; Stigson, M. 2006: Proteomic evaluation of neonatal exposure to 2,2 ,4,4 ,5-pentabromodiphenyl ether. Environmental Health Perspectives 114(2): 254-259
Tian, Q. 2006: Proteomic exploration of the Wnt/beta-catenin pathway. Current Opinion in Molecular Therapeutics 8(3): 191-197
Enose, Y.; Destache, C.J.; Mack, A.L.; Anderson, J.R.; Ullrich, F.; Ciborowski, P.S.; Gendelman, H.E. 2005: Proteomic fingerprints distinguish microglia, bone marrow, and spleen macrophage populations. Glia 51(3): 161-172
Martínez-Ruiz, A.; Lamas, S. 2007: Proteomic identification of S-nitrosylated proteins in endothelial cells. Methods in Molecular Biology 357: 215-223
Yamaguchi, K.; Subramanian, A.R. 2003: Proteomic identification of all plastid-specific ribosomal proteins in higher plant chloroplast 30S ribosomal subunit. European Journal of Biochemistry 270(2): 190-205
Wang, K.K.W.; Ottens, A.K.; Liu, M.C.; Lewis, S.B.; Meegan, C.; Oli, M.W.; Tortella, F.C.; Hayes, R.L. 2005: Proteomic identification of biomarkers of traumatic brain injury. Expert Review of Proteomics 2(4): 603-614
Rehman, A.; Chahal, M.S.; Tang, X.; Bruce, J.E.; Pommier, Y.; Daoud, S.S. 2005: Proteomic identification of heat shock protein 90 as a candidate target for p53 mutation reactivation by PRIMA-1 in breast cancer cells. Breast Cancer Research: Bcr 7(5): R765-R774
Poon, H.F.; Farr, S.A.; Banks, W.A.; Pierce, W.M.; Klein, J.B.; Morley, J.E.; Butterfield, D.A. 2005: Proteomic identification of less oxidized brain proteins in aged senescence-accelerated mice following administration of antisense oligonucleotide directed at the Abeta region of amyloid precursor protein. Brain Research. Molecular Brain Research 138(1): 8-16
Liu, H.-C.; Hu, C.-J.; Chang, J.-G.; Sung, S.-M.; Lee, L.-S.; Yuan, R.-Y.; Leu, S.-J. 2006: Proteomic identification of lower apolipoprotein A-i in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders 21(3): 155-161
Boyd-Kimball, D.; Castegna, A.; Sultana, R.; Poon, H.F.; Petroze, R.; Lynn, B.C.; Klein, J.B.; Butterfield, D.A. 2005: Proteomic identification of proteins oxidized by Abeta(1-42) in synaptosomes: implications for Alzheimer's disease. Brain Research 1044(2): 206-215
Boyd-Kimball, D.; Poon, H.F.; Lynn, B.C.; Cai, J.; Pierce, W.M.; Klein, J.B.; Ferguson, J.; Link, C.D.; Butterfield, D.A. 2006: Proteomic identification of proteins specifically oxidized in Caenorhabditis elegans expressing human Abeta(1-42): implications for Alzheimer's disease. Neurobiology of Aging 27(9): 1239-1249
Russell, S.A.; Old, W.; Resing, K.A.; Hunter, L. 2004: Proteomic informatics. International Review of Neurobiology 61: 127-157
Haley-Vicente, D.; Edwards, D.J. 2003: Proteomic informatics: in silico methods lead to data management challenges. Current Opinion in Drug Discovery and Development 6(3): 322-332
Denison, C.; Kirkpatrick, D.S.; Gygi, S.P. 2005: Proteomic insights into ubiquitin and ubiquitin-like proteins. Current Opinion in Chemical Biology 9(1): 69-75
De Palma, S.; Morandi, L.; Mariani, E.; Begum, S.; Cerretelli, P.; Wait, R.; Gelfi, C. 2006: Proteomic investigation of the molecular pathophysiology of dysferlinopathy. Proteomics 6(1): 379-385
Vracko, M.; Basak, S.C.; Geiss, K.; Witzmann, F. 2006: Proteomic maps-toxicity relationship of halocarbons studied with similarity index and genetic algorithm. Journal of Chemical Information and Modeling 46(1): 130-136
Aulak, K.S.; Koeck, T.; Crabb, J.W.; Stuehr, D.J. 2004: Proteomic method for identification of tyrosine-nitrated proteins. Methods in Molecular Biology 279: 151-165
Brock, J.W.C.; Cotham, W.C.; Ames, J.M.; Thorpe, S.R.; Baynes, J.W. 2005: Proteomic method for the quantification of methionine sulfoxide. Annals of the new York Academy of Sciences 1043: 284-289
Kahwash, E.B.; Barbacioru, C.; Cowden, D.J.; Saltz, J. 2003: Proteomic patterns analysis: a new era of screening cancers. AMIA . Annual Symposium Proceedings. AMIA Symposium 2003: 885
Conrads, T.P.; Hood, B.L.; Issaq, H.J.; Veenstra, T.D. 2004: Proteomic patterns as a diagnostic tool for early-stage cancer: a review of its progress to a clinically relevant tool. Molecular Diagnosis: a Journal Devoted to the Understanding of Human Disease Through the Clinical Application of Molecular Biology 8(2): 77-85
Whiteley, G.R. 2006: Proteomic patterns for cancer diagnosis--promise and challenges. Molecular Biosystems 2(8): 358-363
Diamandis, E.P. 2004: Proteomic patterns to identify ovarian cancer: 3 years on. Expert Review of Molecular Diagnostics 4(5): 575-577
Everall, I.; Grant, I. 2004: Proteomic pointers in HIV neurocognitive disorder. Lancet 363(9415): 1091-1092
Steinert, R.; von Hoegen, P.; Fels, L.M.; Günther, K.; Lippert, H.; Reymond, M.A. 2003: Proteomic prediction of disease outcome in cancer : clinical framework and current status. American Journal of Pharmacogenomics: Genomics-Related Research in Drug Development and Clinical Practice 3(2): 107-115
Hancock, W.S. 2002: Proteomic priorities. Journal of Proteome Research 1(2): 105
Shen, J.; Wu, M.; Yu, Y. 2006: Proteomic profiling for cellular responses to different concentrations of N-methyl-N'-nitro-N-nitrosoguanidine. Journal of Proteome Research 5(2): 385-395
Melle, C.; Kaufmann, R.; Hommann, M.; Bleul, A.; Driesch, D.; Ernst, G.ün.; von Eggeling, F. 2004: Proteomic profiling in microdissected hepatocellular carcinoma tissue using ProteinChip technology. International Journal of Oncology 24(4): 885-891
Holt, G.E.; Schwartz, H.S.; Caldwell, R.L. 2006: Proteomic profiling in musculoskeletal oncology by MALdi mass spectrometry. Clinical Orthopaedics and Related Research 450: 105-110
Neher, S.B.; Villén, J.; Oakes, E.C.; Bakalarski, C.E.; Sauer, R.T.; Gygi, S.P.; Baker, T.A. 2006: Proteomic profiling of ClpXP substrates after DNA damage reveals extensive instability within SOS regulon. Molecular Cell 22(2): 193-204
Yanes, O.; Avilés, F.X.; Wenzel, R.; Nazabal, A.; Zenobi, R.; Calvete, J.J. 2007: Proteomic profiling of a snake venom using high mass detection MALDI-TOF mass spectrometry. Journal of the American Society for Mass Spectrometry 18(4): 600-606
Shau, H.; Chandler, G.S.; Whitelegge, J.P.; Gornbein, J.A.; Faull, K.F.; Chang, H.R. 2003: Proteomic profiling of cancer biomarkers. Briefings in Functional Genomics and Proteomics 2(2): 147-158
Bandow, J.E.; Hecker, M. 2007: Proteomic profiling of cellular stresses in Bacillus subtilis reveals cellular networks and assists in elucidating antibiotic mechanisms of action. Progress in Drug Research. Fortschritte der Arzneimittelforschung. Progres des Recherches Pharmaceutiques 64(79): 81-79,101
Blonder, J.; Xiao, Z.; Veenstra, T.D. 2006: Proteomic profiling of differentiating osteoblasts. Expert Review of Proteomics 3(5): 483-496
Yang, J.-W.; Czech, T.; Lubec, G. 2004: Proteomic profiling of human hippocampus. Electrophoresis 25(7-8): 1169-1174
Hettick, J.M.; Kashon, M.L.; Simpson, J.P.; Siegel, P.D.; Mazurek, G.H.; Weissman, D.N. 2004: Proteomic profiling of intact mycobacteria by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Analytical Chemistry 76(19): 5769-5776
Fan, G.; Molstad, M.; Braziel, R.M.; Standley, M.; Huang, J.; Rodgers, W.; Nagalla, S. 2005: Proteomic profiling of mature CD10+ B-cell lymphomas. American Journal of Clinical Pathology 124(6): 920-929
Hauck, S.M.; Suppmann, S.; Ueffing, M. 2003: Proteomic profiling of primary retinal Müller glia cells reveals a shift in expression patterns upon adaptation to in vitro conditions. Glia 44(3): 251-263
Ye, N.-S.; Chen, J.; Luo, G.-A.; Zhang, R.-L.; Zhao, Y.-F.; Wang, Y.-M. 2006: Proteomic profiling of rat bone marrow mesenchymal stem cells induced by 5-azacytidine. Stem Cells and Development 15(5): 665-676
Solassol, J.ér.ôm.; Marin, P.; Maudelonde, T.; Mangé, A. 2005: Proteomic profiling: the potential of Seldi-Tof for the identification of new cancer biomarkers. Bulletin du Cancer 92(9): 763-768
Morita, A.; Miyagi, E.; Yasumitsu, H.; Kawasaki, H.; Hirano, H.; Hirahara, F. 2006: Proteomic search for potential diagnostic markers and therapeutic targets for ovarian clear cell adenocarcinoma. Proteomics 6(21): 5880-5890
Okano, T.; Kondo, T.; Fujii, K.; Nishimura, T.; Takano, T.; Ohe, Y.; Tsuta, K.; Matsuno, Y.; Gemma, A.; Kato, H.; Kudoh, S.; Hirohashi, S. 2007: Proteomic signature corresponding to the response to gefitinib (Iressa, ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor in lung adenocarcinoma. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 13(3): 799-805
Suehara, Y.; Kondo, T.; Fujii, K.; Hasegawa, T.; Kawai, A.; Seki, K.; Beppu, Y.; Nishimura, T.; Kurosawa, H.; Hirohashi, S. 2006: Proteomic signatures corresponding to histological classification and grading of soft-tissue sarcomas. Proteomics 6(15): 4402-4409
Sender, U.; Bandow, J.; Engelmann, S.; Lindequist, U.; Hecker, M. 2004: Proteomic signatures for daunomycin and adriamycin in Bacillus subtilis. Die Pharmazie 59(1): 65-70
Seike, M.; Kondo, T.; Fujii, K.; Okano, T.; Yamada, T.; Matsuno, Y.; Gemma, A.; Kudoh, S.; Hirohashi, S. 2005: Proteomic signatures for histological types of lung cancer. Proteomics 5(11): 2939-2948
Takahashi, N.; Yanagida, M.; Fujiyama, S.; Hayano, T.; Isobe, T. 2003: Proteomic snapshot analyses of preribosomal ribonucleoprotein complexes formed at various stages of ribosome biogenesis in yeast and mammalian cells. Mass Spectrometry Reviews 22(5): 287-317
Alessandro, R.; Fontana, S.; Kohn, E.; De Leo, G. 2005: Proteomic strategies and their application in cancer research. Tumori 91(6): 447-455
Ferguson, R.E.; Selby, P.J.; Banks, R.E. 2004: Proteomic studies in urological malignancies. Contributions to Nephrology 141: 257-279
Shishkin, S.S.; Kovalyov, L.I.; Kovalyova, M.A. 2004: Proteomic studies of human and other vertebrate muscle proteins. BIOCHEMISTRY. Biokhimiia 69(11): 1283-1298
Bruce, C.R.; Van West, P.; Grenville-Briggs, L.J. 2006: Proteomic studies of plant-pathogenic oomycetes and fungi. Methods of Biochemical Analysis 49: 271-283
Kadri, T.; Lataillade, J.-J.; Doucet, C.; Marie, A.; Ernou, I.; Bourin, P.; Joubert-Caron, R.; Caron, M.; Lutomski, D. 2005: Proteomic study of Galectin-1 expression in human mesenchymal stem cells. Stem Cells and Development 14(2): 204-212
Sprenger, R.R.; Horrevoets, A.J.G. 2007: Proteomic study of caveolae and rafts isolated from human endothelial cells. Methods in Molecular Biology 357: 199-213
Murphy, V.E.; Johnson, R.F.; Wang, Y.-C.; Akinsanya, K.; Gibson, P.G.; Smith, R.; Clifton, V.L. 2006: Proteomic study of plasma proteins in pregnant women with asthma. Respirology 11(1): 41-48
Xiang, Y.; Sekine, T.; Nakamura, H.; Imajoh-Ohmi, S.; Fukuda, H.; Nishioka, K.; Kato, T. 2004: Proteomic surveillance of autoimmunity in osteoarthritis: identification of triosephosphate isomerase as an autoantigen in patients with osteoarthritis. Arthritis and Rheumatism 50(5): 1511-1521
Antelmann, H.; Van Dijl, J.M.; Bron, S.; Hecker, M. 2006: Proteomic survey through secretome of Bacillus subtilis. Methods of Biochemical Analysis 49: 179-208
Bao, R.-Y.; Zheng, C.-X.; Zhu, L.-H. 2006: Proteomic technique used in studying ovule development of Chinese pine (Pinus tabulaeformis Carr.). Zhi Wu Sheng Li Yu Fen Zi Sheng Wu Xue Xue Bao 32(4): 497-503
Vimalachandran, D.; Costello, E. 2004: Proteomic technologies and their application to pancreatic cancer. Expert Review of Proteomics 1(4): 493-501
Buhimschi, C.S.; Pettker, C.M.; Magloire, L.K.; Martin, R.; Norwitz, E.; Funai, E.; Buhimschi, I.A. 2005: Proteomic technology and delayed interval delivery in multiple pregnancies. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 90(1): 48-50
Alaoui-Jamali, M.A.; Xu, Y-jie. 2006: Proteomic technology for biomarker profiling in cancer: an update. Journal of Zhejiang University. Science. B 7(6): 411-420
Lill, J. 2003: Proteomic tools for quantitation by mass spectrometry. Mass Spectrometry Reviews 22(3): 182-194
Haniu, H.; Komori, N.; Takemori, N.; Singh, A.; Ash, J.D.; Matsumoto, H. 2006: Proteomic trajectory mapping of biological transformation: Application to developmental mouse retina. Proteomics 6(11): 3251-3261
Bavelloni, A.; Faenza, I.; Cioffi, G.; Piazzi, M.; Parisi, D.; Matic, I.; Maraldi, N.M.; Cocco, L. 2006: Proteomic-based analysis of nuclear signaling: PLCbeta1 affects the expression of the splicing factor SRp20 in Friend erythroleukemia cells. Proteomics 6(21): 5725-5734
Schaub, S.; Rush, D.; Wilkins, J.; Gibson, I.W.; Weiler, T.; Sangster, K.; Nicolle, L.; Karpinski, M.; Jeffery, J.; Nickerson, P. 2004: Proteomic-based detection of urine proteins associated with acute renal allograft rejection. Journal of the American Society of Nephrology: Jasn 15(1): 219-227
Ye, B.; Skates, S.; Mok, S.C.; Horick, N.K.; Rosenberg, H.F.; Vitonis, A.; Edwards, D.; Sluss, P.; Han, W.K.; Berkowitz, R.S.; Cramer, D.W. 2006: Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urine. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 12(2): 432-441
Schaub, S.; Wilkins, J.A.; Antonovici, M.; Krokhin, O.; Weiler, T.; Rush, D.; Nickerson, P. 2005: Proteomic-based identification of cleaved urinary beta2-microglobulin as a potential marker for acute tubular injury in renal allografts. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 5(4 Part 1): 729-738
Arthur, J.M. 2003: Proteomics. Current Opinion in Nephrology and Hypertension 12(4): 423-430
Meyer, H.E. 2003: Proteomics. Analytical and Bioanalytical Chemistry 376(7): 945
Zhu, H.; Bilgin, M.; Snyder, M. 2003: Proteomics. Annual Review of Biochemistry 72: 783-812
De Hoog, C.L.; Mann, M. 2004: Proteomics. Annual Review of Genomics and Human Genetics 5: 267-293
Stults, J.T.; Arnott, D. 2005: Proteomics. Methods in Enzymology 402: 245-289
Tchuvatkina, O.; Shimoni, L.; Ochs, M.F.; Moloshok, T. 2006: Proteomics LIMS: a caBIG project, year 1. AMIA . Annual Symposium Proceedings. AMIA Symposium 2006: 1116
Yang, H.; Liang, C.; Gao, B.; Lu, X.; Li, S. 2003: Proteomics analysis and biochemical activity detection on facial nerve regeneration fluid. Lin Chuang Er Bi Yan Hou Ke Za Zhi 17(1): 37-39
Butterfield, D.A.; Boyd-Kimball, D. 2004: Proteomics analysis in Alzheimer's disease: new insights into mechanisms of neurodegeneration. International Review of Neurobiology 61: 159-188
Kikuchi, T.; Carbone, D.P. 2007: Proteomics analysis in lung cancer: challenges and opportunities. Respirology 12(1): 22-28
Sun, N.; Beck, F.; Knispel, R.W.; Siedler, F.; Scheffer, B.; Nickell, S.; Baumeister, W.; Nagy, I.án. 2007: Proteomics analysis of Thermoplasma acidophilum with a focus on protein complexes. Molecular and Cellular Proteomics: Mcp 6(3): 492-502
An, J.; Sun, J.-Y.; Yuan, Q.; Tian, H.-Y.; Qiu, W.-L.; Guo, W.; Zhao, F.-K. 2004: Proteomics analysis of differentially expressed metastasis-associated proteins in adenoid cystic carcinoma cell lines of human salivary gland. Oral Oncology 40(4): 400-408
Trerotola, M.; Vacca, G.; Piantelli, M.; Alberti, S. 2005: Proteomics analysis of solid tumors. Pathologica 97(4): 189-190
Orchard, S.; Apweiler, R.; Barkovich, R.; Field, D.; Garavelli, J.S.; Horn, D.; Jones, A.; Jones, P.; Julian, R.; McNally, R.; Nerothin, J.; Paton, N.; Pizarro, A.; Seymour, S.; Taylor, C.; Wiemann, S.; Hermjakob, H. 2006: Proteomics and Beyond: a report on the 3rd Annual Spring Workshop of the HUPO-PSI 21-23 April 2006, San Francisco, CA, USA. Proteomics 6(16): 4439-4443
Witzmann, F.A.; Strother, W.N. 2004: Proteomics and alcoholism. International Review of Neurobiology 61: 189-214
Machour, N.; Gilbert, D.èl.; Vittecoq, O.; Costa, O.; Tron, F.ço.; Charlionet, R. 2005: Proteomics and autoantibody. Medecine Sciences: M/S 21(8-9): 759-764
Cottingham, K. 2006: Proteomics and behavior. Journal of Proteome Research 5(2): 229
Giometti, C.S. 2003: Proteomics and bioinformatics. Advances in Protein Chemistry 65: 353-369
Khan, A.S.; Mujer, C.V.; Alefantis, T.G.; Connolly, J.P.; Mayr, U.B.; Walcher, P.; Lubitz, W.; Delvecchio, V.G. 2006: Proteomics and bioinformatics strategies to design countermeasures against infectious threat agents. Journal of Chemical Information and Modeling 46(1): 111-115
Mathelin, C.; Tomasetto, C.; Cromer, A.; Rio, M.-C. 2006: Proteomics and breast cancer. Gynecologie Obstetrique and Fertilite 34(12): 1161-1169
Hondermarck, H. 2006: Proteomics and breast cancer: new perspectives and limitations. Pathologie-Biologie 54(4): 194-198
Vivanco, F.; López-Bescós, L.; Tuñón, J.é; Egido, J.ús. 2003: Proteomics and cardiovascular disease. Revista Espanola de Cardiologia 56(3): 289-302
Roblick, U.J.; Auer, G. 2005: Proteomics and clinical surgery. British Journal of Surgery 92(12): 1464-1465
Thongboonkerd, V.; Barati, M.T.; McLeish, K.R.; Pierce, W.M.; Epstein, P.N.; Klein, J.B. 2004: Proteomics and diabetic nephropathy. Contributions to Nephrology 141: 142-154
Nagaike, K. 2005: Proteomics and diagnostic application. Rinsho Byori. Japanese Journal of Clinical Pathology 53(3): 239-245
Marko-Varga, Görgy.; Fehniger, T.E. 2004: Proteomics and disease--the challenges for technology and discovery. Journal of Proteome Research 3(2): 167-178
Kavallaris, M.; Marshall, G.M. 2005: Proteomics and disease: opportunities and challenges. Medical Journal of Australia 182(11): 575-579
Jain, K.K. 2004: Proteomics and drug discovery. Contributions to Nephrology 141: 308-327
Murakami, K.; Nishigaki, R.; Kazuki, Y.; Kadota, M.; Oshimura, M. 2004: Proteomics and epigenetics learned from down syndrome model mouse. SEIKAGAKU. Journal of Japanese Biochemical Society 76(10): 1296-1304
Fu, Q.; Van Eyk, J.E. 2006: Proteomics and heart disease: identifying biomarkers of clinical utility. Expert Review of Proteomics 3(2): 237-249
Thongboonkerd, V.; Klein, J.B. 2004: Proteomics and hypertension. Contributions to Nephrology 141: 245-256
Hou, Z.-j.; Li, Y.-q. 2006: Proteomics and its application in the research of prostatic carcinoma. Zhonghua Nan Ke Xue 12(4): 358-361
Lacheta, J.; Cibula, D.; Freitag, P.; Zivný, J. 2004: Proteomics and its importance for gynecological oncology. Ceska Gynekologie 69(5): 384-387
Nishimura, T. 2004: Proteomics and its role in drug discovery and development. Seikagaku. Journal of Japanese Biochemical Society 76(10): 1344-1352
Petrák, J. 2005: Proteomics and its role in medicine. Casopis Lekaru Ceskych 144(6): 365-370; Discussion: 370-371
McGregor, E.; De Souza, A. 2006: Proteomics and laser microdissection. Methods in Molecular Biology 333: 291-304
Onogi, H.; Inagi, R.; Miyata, T.; Nangaku, M.; Kurokawa, K. 2004: Proteomics and mesangial cell: serpin, megsin and plasmin. Contributions to Nephrology 141: 212-220
Mayr, M.; Madhu, B.; Xu, Q. 2007: Proteomics and metabolomics combined in cardiovascular research. Trends in Cardiovascular Medicine 17(2): 43-48
Witzmann, F.A.; Li, J. 2004: Proteomics and nephrotoxicity. Contributions to Nephrology 141: 104-123
Armandola, E.A. 2003: Proteomics and new therapeutic strategies. Medgenmed: Medscape General Medicine 5(2): 21
Posadas, E.M.; Davidson, B.; Kohn, E.C. 2004: Proteomics and ovarian cancer: implications for diagnosis and treatment: a critical review of the recent literature. Current Opinion in Oncology 16(5): 478-484
Bedossa, P. 2003: Proteomics and pathology. Annales de Pathologie (Special Issue 1): S25-S26
Jain, K.K. 2003: Proteomics and protein arrays Europa. Pharmacogenomics 4(4): 383-385
Werner, T. 2004: Proteomics and regulomics: the yin and yang of functional genomics. Mass Spectrometry Reviews 23(1): 25-33
Mazzulli, T.; Low, D.E.; Poutanen, S.M. 2005: Proteomics and severe acute respiratory syndrome (SARS): emerging technology meets emerging pathogen. Clinical Chemistry 51(1): 6-7
Ecelbarger, C.A. 2004: Proteomics and sodium transport. Contributions to Nephrology 141: 124-141
Hittel, D.S.; Hathout, Y.; Hoffman, E.P. 2007: Proteomics and systems biology in exercise and sport sciences research. Exercise and Sport Sciences Reviews 35(1): 5-11
Neumann, T. 2002: Proteomics and the Proteome - IBC's Fifth Annual Conference. 18-20 February, Geneva, Switzerland. IDrugs: the investigational drugs journal 5(3): 234-236
McGuinness, P.E. 2004: Proteomics and the early identification of disease. Scanning 26(6): 319
Rees-Unwin, K.S.; Morgan, G.J.; Davies, F.E. 2004: Proteomics and the haematologist. Clinical and Laboratory Haematology 26(2): 77-86
Zhan, X.; Evans, C.-O.; Oyesiku, N.M.; Desiderio, D.M. 2003: Proteomics and transcriptomics analyses of secretagogin down-regulation in human non-functional pituitary adenomas. Pituitary 6(4): 189-202
Kommu, S.; Sharifi, R.; Edwards, S.; Eeles, R. 2004: Proteomics and urine analysis: a potential promising new tool in urology. Bju International 93(9): 1172-1173
Morris, K. 2003: Proteomics approach could produce blood test for AIDS dementia. LANCET. Neurology 2(8): 455
Zhou, M.; Conrads, T.P.; Veenstra, T.D. 2005: Proteomics approaches to biomarker detection. Briefings in Functional Genomics and Proteomics 4(1): 69-75
Godovac-Zimmermann, J.; Brown, L.R. 2003: Proteomics approaches to elucidation of signal transduction pathways. Current Opinion in Molecular Therapeutics 5(3): 241-249
Camerini, S.; Polci, M.L.; Bachi, A. 2005: Proteomics approaches to study the redox state of cysteine-containing proteins. Annali Dell'istituto Superiore di Sanita 41(4): 451-457
Shin, B.Kyung.; Wang, H.; Hanash, S. 2002: Proteomics approaches to uncover the repertoire of circulating biomarkers for breast cancer. Journal of Mammary Gland Biology and Neoplasia 7(4): 407-413
Liu, B.C.S.; Ehrlich, J.R. 2006: Proteomics approaches to urologic diseases. Expert Review of Proteomics 3(3): 283-296
Mathesius, U.; Imin, N.; Natera, S.H.A.; Rolfe, B.G. 2003: Proteomics as a functional genomics tool. Methods in Molecular Biology 236: 395-414
Bogdanov, B.; Smith, R.D. 2005: Proteomics by FTICR mass spectrometry: top down and bottom up. Mass Spectrometry Reviews 24(2): 168-200
Garry, C.E.; Garry, R.F. 2004: Proteomics computational analyses suggest that the carboxyl terminal glycoproteins of Bunyaviruses are class Ii viral fusion protein (beta-penetrenes). Theoretical Biology and Medical Modelling 1: 10
Erickson, B.E. 2005: Proteomics data back up soy health claims. Journal of Proteome Research 4(2): 219
Dean, R.A.; Overall, C.M. 2007: Proteomics discovery of metalloproteinase substrates in the cellular context by iTRAQ labeling reveals a diverse MMP-2 substrate degradome. Molecular and Cellular Proteomics: Mcp 6(4): 611-623
Gotthardt, D.; Blancheteau, V.; Bosserhoff, A.; Ruppert, T.; Delorenzi, M.; Soldati, T. 2006: Proteomics fingerprinting of phagosome maturation and evidence for the role of a Galpha during uptake. Molecular and Cellular Proteomics: Mcp 5(12): 2228-2243
Drake, R.R.; Deng, Y.; Schwegler, E.E.; Gravenstein, S. 2005: Proteomics for biodefense applications: progress and opportunities. Expert Review of Proteomics 2(2): 203-213
Mosca, P.J.; Lyerly, H.K.; Ching, C.D.; Hobeika, A.C.; Clay, T.M.; Morse, M.A. 2003: Proteomics for monitoring immune responses to cancer vaccines. Current Opinion in Molecular Therapeutics 5(1): 39-43
Casado, B.ña. 2004: Proteomics for nasal secretion analysis. Current Allergy and Asthma Reports 4(3): 224-229
Ornstein, D.K.; Tyson, D.R. 2006: Proteomics for the identification of new prostate cancer biomarkers. Urologic Oncology 24(3): 231-236
McCulloch, C.A. 2006: Proteomics for the periodontium: current strategies and future promise. Periodontology 2000 40: 173-183
Johnson, H.; Gaskell, S.J. 2006: Proteomics gets faster and smarter. Genome Biology 7(11): 331
Sage, L. 2005: Proteomics gets out of a fix. Journal of Proteome Research 4(6): 1903-1904
Figeys, D. 2003: Proteomics in 2002: a year of technical development and wide-ranging applications. Analytical Chemistry 75(12): 2891-2905
He, F. 2006: Proteomics in China. Proteomics 6(2): 397-403
Lilley, K.S.; Griffiths, D.R. 2003: Proteomics in Drosophila melanogaster. Briefings in Functional Genomics and Proteomics 2(2): 106-113
Sjøholt, G.; Anensen, N.; Wergeland, L.; Mc Cormack, E.; Bruserud, Øy.; Gjertsen, B.ør.T. 2005: Proteomics in acute myelogenous leukaemia (AML): methodological strategies and identification of protein targets for novel antileukaemic therapy. Current Drug Targets 6(6): 631-646
Gafni, A. 2004: Proteomics in aging-related research. Science of Aging Knowledge Environment: Sage Ke 45: Pe41
Anni, H.; Israel, Y. 2002: Proteomics in alcohol research. Alcohol Research and Health: the Journal of the National Institute on Alcohol Abuse and Alcoholism 26(3): 219-232
Hu, W.; Wu, W.; Kobayashi, R.; Kavanagh, J.J. 2004: Proteomics in cancer screening and management in gynecologic cancer. Current Oncology Reports 6(6): 456-462
Shoshan, S.H.; Admon, A. 2005: Proteomics in cancer vaccine development. Expert Review of Proteomics 2(2): 229-241
Matt, P.; Carrel, T.; White, M.; Lefkovits, I.; Van Eyk, J. 2007: Proteomics in cardiovascular surgery. Journal of Thoracic and Cardiovascular Surgery 133(1): 210-214
Shoshan, S.H.; Admon, A. 2005: Proteomics in clinical laboratory diagnosis. Advances in Clinical Chemistry 39: 159-184
Veenstra, T.D.; Srivastava, S. 2003: Proteomics in diagnostics. Disease Markers 19(4-5): 167-168
Ebert, M.P.A.; Yu, J.; Lordick, F.; Röcken, C. 2006: Proteomics in gastrointestinal cancer. Annals of Oncology: Official Journal of the European Society for Medical Oncology 17(Suppl 10): X253-X258
Caron, M.; Joubert-Caron, R. 2005: Proteomics in hematologic malignancies. Expert Review of Proteomics 2(4): 567-576
Niwayama, S. 2006: Proteomics in medicinal chemistry. Mini Reviews in Medicinal Chemistry 6(2): 241-246
Schulenborg, T.; Schmidt, O.; van Hall, A.; Meyer, H.E.; Hamacher, M.; Marcus, K. 2006: Proteomics in neurodegeneration--disease driven approaches. Journal of Neural Transmission 113(8): 1055-1073
Zhang, X.-Q.; Jiang, Y.; Li, Y.-M.; He, F.-C. 2006: Proteomics in nonalcoholic fatty liver research. Zhonghua Gan Zang Bing Za Zhi 14(10): 798-800
Kussmann, M.; Affolter, M.; Fay, L.B. 2005: Proteomics in nutrition and health. Combinatorial Chemistry and High Throughput Screening 8(8): 679-696
Guo, J.; Wu, K.; Yu, M. 2003: Proteomics in ophthalmology. Yan Ke Xue Bao 19(2): 67-70
Löhr, M.; Faissner, R. 2004: Proteomics in pancreatic disease. Pancreatology: Official Journal of the International Association of Pancreatology . 4(2): 67-75
Perrotta, P.L.; Bahou, W.F. 2004: Proteomics in platelet science. Current Hematology Reports 3(6): 462-469
Bañez, L.L.; Srivastava, S.; Moul, J.W. 2005: Proteomics in prostate cancer. Current Opinion in Urology 15(3): 151-156
Schaub, S.; Wilkins, J.A.; Nickerson, P. 2004: Proteomics in renal transplantation: opportunities and challenges. Clinical Transplants 2004: 253-260
Ali, M.; Manolios, N. 2005: Proteomics in rheumatology: a new direction for old diseases. Seminars in Arthritis and Rheumatism 35(2): 67-76
Souchelnytskyi, S. 2002: Proteomics in studies of signal transduction in epithelial cells. Journal of Mammary Gland Biology and Neoplasia 7(4): 359-371
Naaby-Hansen, S.; Nagano, K.; Gaffney, P.; Masters, J.R.W.; Cramer, R. 2003: Proteomics in the analysis of prostate cancer. Methods in Molecular Medicine 81: 277-297
Srivastava, S.; Srivastava, R-Gopal. 2005: Proteomics in the forefront of cancer biomarker discovery. Journal of Proteome Research 4(4): 1098-1103
Li, Y.-p.; Hu, C.-p. 2005: Proteomics in the pathogenetic study of lung cancer. Zhonghua Jie he He Hu Xi Za Zhi 28(4): 281-283
Morrison, R.S.; Kinoshita, Y.; Johnson, M.D.; Conrads, T.P. 2003: Proteomics in the postgenomic age. Advances in Protein Chemistry 65: 1-23
Parent, R.; Beretta, L. 2005: Proteomics in the study of liver pathology. Journal of Hepatology 43(1): 177-183
Wang, X. 2007: Proteomics in the study of organ dysfunction. Expert Review of Proteomics 4(1): 1-3
Everley, P.A.; Zetter, B.R. 2005: Proteomics in tumor progression and metastasis. Annals of the new York Academy of Sciences 1059: 1-10
Sheffield, L.G.; Gavinski, J.J. 2003: Proteomics methods for probing molecular mechanisms in signal transduction. Journal of Animal Science 81(Suppl 3): 48-57
Cavicchioli, R.; Goodchild, A.; Raftery, M. 2006: Proteomics of Archaea. Methods of Biochemical Analysis 49: 57-72
Burkovski, A. 2006: Proteomics of Corynebacterium glutamicum: essential industrial bacterium. Methods of Biochemical Analysis 49: 137-147
Kilstrup, M. 2006: Proteomics of Lactococcus lactis: phenotypes for a domestic bacterium. Methods of Biochemical Analysis 49: 149-178
Hecker, M.; Engelmann, S.; Cordwell, S.J. 2003: Proteomics of Staphylococcus aureus--current state and future challenges. Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 787(1): 179-195
Souchelnytskyi, S. 2005: Proteomics of TGF-beta signaling and its impact on breast cancer. Expert Review of Proteomics 2(6): 925-935
Cash, P. 2003: Proteomics of bacterial pathogens. Advances in Biochemical Engineering/Biotechnology 83: 93-115
Stoppini, M.; Mangione, P.; Monti, M.; Giorgetti, S.; Marchese, L.; Arcidiaco, P.; Verga, L.; Segagni, S.; Pucci, P.; Merlini, G.; Bellotti, V. 2005: Proteomics of beta2-microglobulin amyloid fibrils. Biochimica et Biophysica Acta 1753(1): 23-33
Strzeżek, J.; Wysocki, P.ł; Kordan, W.ła.ła.; Kuklińska, M.; Mogielnicka, M.; Soliwoda, D.; Fraser, L. 2005: Proteomics of boar seminal plasma - current studies and possibility of their application in biotechnology of animal reproduction. Reproductive Biology 5(3): 279-290
Qualtieri, A.; Urso, E.; Le Pera, M.; Scornaienchi, M.; Quattrone, A.; Di Donna, L.; Napoli, A.; Sindona, G. 2006: Proteomics of bovine myelin sheath: characterization of a truncated form of P0 by MALDI-TOF/TOF mass spectrometry. Journal of the American Society for Mass Spectrometry 17(2): 117-123
Haseloff, R.F.; Krause, E.; Blasig, I.E. 2003: Proteomics of brain endothelium. Separation of proteins by two-dimensional gel electrophoresis and identification by mass spectrometry. Methods in Molecular Medicine 89: 465-477
Hondermarck, H. 2006: Proteomics of breast cancer: from differential to functional analysis. Journal de la Societe de Biologie 200(2): 199-202
Tai, L.K.; Zhang, D.H.; Wong, L.L.; Koay, E.S.C. 2004: Proteomics of breast cancer: enhanced expression of CK19 in HER-2/neu-positive tumours. Annals of the Academy of Medicine Singapore 33(5 Suppl): S17-S18
Zhang, D.-H.; Tai, L.K.; Wong, L.L.; Sethi, S.K.; Koay, E.S.C. 2005: Proteomics of breast cancer: enhanced expression of cytokeratin19 in human epidermal growth factor receptor type 2 positive breast tumors. Proteomics 5(7): 1797-1805
El Yazidi-Belkoura, I.; Adriaenssens, E.; Vercoutter-Edouart, A.-S.; Lemoine, J.ér.ôm.; Nurcombe, V.; Hondermarck, H. 2002: Proteomics of breast cancer: outcomes and prospects. Technology in Cancer Research and Treatment 1(4): 287-296
Kuramitsu, Y.; Nakamura, K. 2004: Proteomics of cancer. Seikagaku. Journal of Japanese Biochemical Society 76(10): 1353-1358
Sheikh, A.M.; Barrett, C.; Villamizar, N.; Alzate, O.; Miller, S.; Shelburne, J.; Lodge, A.; Lawson, J.; Jaggers, J. 2006: Proteomics of cerebral injury in a neonatal model of cardiopulmonary bypass with deep hypothermic circulatory arrest. Journal of Thoracic and Cardiovascular Surgery 132(4): 820-828
Föcking, M.; Besselmann, M.; Trapp, T. 2006: Proteomics of experimental stroke in mice. Acta Neurobiologiae Experimentalis 66(4): 273-278
Whitelegge, J.P.; Gómez, S.M.; Faull, K.F. 2003: Proteomics of membrane proteins. Advances in Protein Chemistry 65: 271-307
Kulkarni, P.P.; She, Y.M.; Smith, S.D.; Roberts, E.A.; Sarkar, B. 2006: Proteomics of metal transport and metal-associated diseases. Chemistry 12(9): 2410-2422
Raimondo, F.; Ceppi, P.; Guidi, K.; Masserini, M.; Foletti, C.; Pitto, M. 2005: Proteomics of plasma membrane microdomains. Expert Review of Proteomics 2(5): 793-807
Mitsui, K.; Doi, H.; Nukina, N. 2006: Proteomics of polyglutamine aggregates. Methods in Enzymology 412: 63-76
Cottingham, K. 2006: Proteomics of starvation. Journal of Proteome Research 5(9): 2075
Li, K.Wan. 2007: Proteomics of synapse. Analytical and Bioanalytical Chemistry 387(1): 25-28
Tribl, F.; Marcus, K.; Bringmann, G.; Meyer, H.E.; Gerlach, M.; Riederer, P. 2006: Proteomics of the human brain: sub-proteomes might hold the key to handle brain complexity. Journal of Neural Transmission 113(8): 1041-1054
Sims, P.F.G.; Hyde, J.E. 2006: Proteomics of the human malaria parasite Plasmodium falciparum. Expert Review of Proteomics 3(1): 87-95
Li, Z.; Zhao, X.; Yang, J.; Wei, Y. 2005: Proteomics profile changes in cisplatin-treated human ovarian cancer cell strain. Science in China. Series C Life Sciences 48(6): 648-657
Anonymous 2003: Proteomics research aids cancer diagnosis and treatment. Oncology 17(6): 794 814
Erickson, B.E. 2005: Proteomics reveals effects effects of aquaculture on fish. Journal of Proteome Research 4(3): 667
Mukhopadhyay, R. 2006: Proteomics reveals proteins in paint. Analytical Chemistry 78(5): 1379
Huang, C.-M.; Elmets, C.A.; Tang, D.-c.C.; Li, F.; Yusuf, N. 2004: Proteomics reveals that proteins expressed during the early stage of Bacillus anthracis infection are potential targets for the development of vaccines and drugs. Genomics Proteomics and Bioinformatics 2(3): 143-151
Wang, K.K.W.; Ottens, A.; Haskins, W.; Liu, M.C.; Kobeissy, F.; Denslow, N.; Chen, S.; Hayes, R.L. 2004: Proteomics studies of traumatic brain injury. International Review of Neurobiology 61: 215-240
O'Connor, M. 2006: Proteomics success story. Novel biomarkers for DNA damage response pathways: insights and applications for cancer therapy. Proteomics 6(Suppl 2): 69-71
Souchelnytskyi, S.; Lomnytska, M.; Dubrovska, A.; Hellman, U.; Volodko, N. 2006: Proteomics success story. Towards early detection of breast and ovarian cancer: plasma proteomics as a tool to find novel markers. Proteomics 6(Suppl 2): 65-68
Roxo-Rosa, M.ón.; Davezac, N.ël.; Bensalem, N.; Majumder, M.; Heda, G.D.; Simas, A.; Penque, D.; Amaral, M.D.; Lukacs, G.L.; Edelman, A. 2004: Proteomics techniques for cystic fibrosis research. Journal of Cystic Fibrosis: Official Journal of the European Cystic Fibrosis Society 3(Suppl 2): 85-89
Li, C.-Y.; Li, L. 2005: Proteomics techniques in the investigation of nervous system diseases. Sheng Li Ke Xue Jin Zhan 36(3): 286-289
Yang, H.; Zhang, J.; Zhang, W.; Long, W.; Zhang, X.-b. 2006: Proteomics technology for screening biomarkers of oligospermic candidates. Zhonghua Nan Ke Xue 12(1): 39-42
Buhimschi, I.A.; Buhimschi, C.S.; Christner, R.; Weiner, C.P. 2005: Proteomics technology for the accurate diagnosis of inflammation in twin pregnancies. Bjog: An International Journal of Obstetrics and Gynaecology 112(2): 250-255
Ornstein, D.K.; Petricoin, E.F. 2004: Proteomics to diagnose human tumors and provide prognostic information. Oncology 18(4): 521-529; Discussion: 529-532
Liu, X.-W.; Lu, F.-G.; Zhang, G.-S.; Wu, X.-P.; You, Y.; Ouyang, C.-H.; Yang, D.-Y. 2004: Proteomics to display tissue repair opposing injury response to LPS-induced liver injury. World Journal of Gastroenterology 10(18): 2701-2705
Thomas, D.P.; Pitarch, A.; Monteoliva, L.; Gil, C.; Lopez-Ribot, J.L. 2006: Proteomics to study Candida albicans biology and pathogenicity. Infectious Disorders Drug Targets 6(4): 335-341
Kondo, T. 2004: Proteomics using two-dimensional polyacrylamide gel electrophoresis and fluorescence dye labeling technology. Seikagaku. Journal of Japanese Biochemical Society 76(4): 385-390
Hancock, W.S. 2002: Proteomics versus immunoassays. Journal of Proteome Research 1(5): 393
You, S.-A.; Wang, Q.K. 2006: Proteomics with two-dimensional gel electrophoresis and mass spectrometry analysis in cardiovascular research. Methods in Molecular Medicine 129: 15-26
Pike, L.J.; Sadler, J.E. 2004: Proteomics, genomics and the future of medical education. Missouri Medicine 101(5): 496-499
Goon, P.K.Y.; Lip, G.Y.H. 2006: Proteomics, metabolomics and circulating endothelial progenitor cells in acute coronary syndromes. Journal of Thrombosis and Thrombolysis 22(2): 155-156
Buhimschi, C.S.; Weiner, C.P.; Buhimschi, I.A. 2006: Proteomics, part II: the emerging role of proteomics over genomics in spontaneous preterm labor/birth. Obstetrical and Gynecological Survey 61(8): 543-553
Rapundalo, S. 2000: Proteomics--CHI's Fourth Annual Conference. 22-23 June 2000, San Francisco, CA, USA. IDrugs: the investigational drugs journal 3(10): 1171-1175
Zvelebil, M. 2001: Proteomics--IBC's fourth annual conference--revolutionary technologies for drug target and biomarker identification. IDrugs: the investigational drugs journal 4(5): 555-556
Marcus, K.; Schmidt, O.; Schaefer, H.; Hamacher, M.; van Hall, A.é; Meyer, H.E. 2004: Proteomics--application to the brain. International Review of Neurobiology 61: 285-311
Jain, K.K. 2002: Proteomics-based anticancer drug discovery and development. Technology in Cancer Research and Treatment 1(4): 231-236
Fujita, Y.; Nakanishi, T.; Hiramatsu, M.; Mabuchi, H.; Miyamoto, Y.; Miyamoto, A.; Shimizu, A.; Tanigawa, N. 2006: Proteomics-based approach identifying autoantibody against peroxiredoxin Vi as a novel serum marker in esophageal squamous cell carcinoma. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 12(21): 6415-6420
Xie, L.; Ying, W.-T.; Li, B.-Y.; Zhang, K.-T.; Qian, X.-H.; Xiang, X.-Q.; Wu, D.-C. 2003: Proteomics-based identification of Maspin differential expression in bronchial epithelial immortalized cells and malignant transformation cells. Ai Zheng 22(5): 463-466
Li, W.-H.; Zhao, J.; Li, H.-Y.; Liu, H.; Li, A.-L.; Wang, H.-X.; Wang, J.; He, K.; Liang, B.; Yu, M.; Shen, B.-F.; Zhang, X.-M. 2006: Proteomics-based identification of autoantibodies in the sera of healthy Chinese individuals from Beijing. Proteomics 6(17): 4781-4789
Huang, L.-J.; Chen, S.-X.; Huang, Y.; Luo, W.-J.; Jiang, H.-H.; Hu, Q.-H.; Zhang, P.-F.; Yi, H. 2006: Proteomics-based identification of secreted protein dihydrodiol dehydrogenase as a novel serum markers of non-small cell lung cancer. Lung Cancer 54(1): 87-94
Loschelder, H.; Homann, A.; Ogrzewalla, K.; Link, G. 2004: Proteomics-based sequence analysis of plant gene expression--the chloroplast transcription apparatus. Phytochemistry 65(12): 1785-1793
Schasfoort, R.B.M. 2004: Proteomics-on-a-chip: the challenge to couple lab-on-a-chip unit operations. Expert Review of Proteomics 1(1): 123-132
Service, R.F. 2003: Proteomics. a sharper focus. Science 302(5649): 1318
Kondro, W. 2005: Proteomics. Canadian global database may move to Singapore after loss of funding. Science 308(5728): 1529
Barai, S.; Rajkamal; Bandopadhayaya, G.P.; Pant, G.S.; Haloi, A.K.; Malhotra, A.; Dhanpathi, H. 2005: Thallium-201 versus Tc99m-glucoheptonate SPECT for evaluation of recurrent brain tumours: a within-subject comparison with pathological correlation. Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia 12(1): 27-31
Service, R.F. 2005: Proteomics. new database to track protein locations. Science 309(5739): 1310
Service, R.F. 2005: Proteomics. Protein chips map yeast kinase network. Science 307(5717): 1854-1855
Service, R.F. 2003: Proteomics. Public projects gear up to chart the protein landscape. Science 302(5649): 1316-1318
Nagy, J.M..; Brown, K.A.. 2002: Proteomics: New Developments in Target Discovery. Drug News and Perspectives 15(9): 601-603
Qoronfleh, M.. W. 2004: Proteomics: the Next Frontier-A Biotech Perspective. Journal of Biomedicine and Biotechnology 3: 121-123
Vij, N. 2003: Proteomics: a novel approach to explore signal exchanges in Rhizobium-legume symbiosis. Indian Journal of Experimental Biology 41(10): 1133-1135
Lawrance, I.C.; Klopcic, B.; Wasinger, V.C. 2005: Proteomics: an overview. Inflammatory Bowel Diseases 11(10): 927-936
Page, M.J.; Griffiths, T.A.M.; Bleackley, M.R.; MacGillivray, R.T.A. 2006: Proteomics: applications relevant to transfusion medicine. Transfusion Medicine Reviews 20(1): 63-74
Gobezie, R.; Millett, P.J.; Sarracino, D.S.; Evans, C.; Thornhill, T.S. 2006: Proteomics: applications to the study of rheumatoid arthritis and osteoarthritis. Journal of the American Academy of Orthopaedic Surgeons 14(6): 325-332
Patterson, S.D. 2004: Proteomics: beginning to realize its promise?. Arthritis and Rheumatism 50(12): 3741-3744
Smith, L. 2006: Proteomics: challenges and emerging technologies, EuroSciCon. Expert Review of Proteomics 3(6): 573-577
Hirsch, J.; Hansen, K.C.; Burlingame, A.L.; Matthay, M.A. 2004: Proteomics: current techniques and potential applications to lung disease. American Journal of Physiology. Lung Cellular and Molecular Physiology 287(1): L1-23
Vitzthum, F.; Behrens, F.; Anderson, N.L.; Shaw, J.H. 2005: Proteomics: from basic research to diagnostic application. a review of requirements and needs. Journal of Proteome Research 4(4): 1086-1097
Lambert, J.-P.; Ethier, M.; Smith, J.C.; Figeys, D. 2005: Proteomics: from gel based to gel free. Analytical Chemistry 77(12): 3771-3787
Formanek, R. 2005: Proteomics: moving beyond the human genome. Fda Consumer 39(6): 18-27
Molloy, M.P.; Witzmann, F.A. 2002: Proteomics: technologies and applications. Briefings in Functional Genomics and Proteomics 1(1): 23-39
Delsuc, N.; Léger, J.-M.; Massip, S.ép.; Huc, I. 2007: Proteomorphous objects from abiotic backbones. Angewandte Chemie 46(1-2): 214-217
Lubner, G.C. 2004: Proteonomica and bioinformatic. Bollettino Chimico Farmaceutico 143(3): 98
Gaehlinger, H. 1955: Proteoses of the stool. La Revue du Praticien 5(12): 1220-1223
Mikaelian, I.; Blades, N.; Churchill, G.A.; Fancher, K.; Knowles, B.B.; Eppig, J.T.; Sundberg, J.P. 2004: Proteotypic classification of spontaneous and transgenic mammary neoplasms. Breast Cancer Research: Bcr 6(6): R668-R679
Rodriguez, C.; Quero, C.; Dominguez, A.; Trigo, M.; Posada de la Paz, M.; Gelpi, E.; Abian, J. 2006: Proteotyping of human haptoglobin by MALDI-TOF profiling: Phenotype distribution in a population of toxic oil syndrome patients. Proteomics 6(Suppl 1): S272-S281
Schurad, B.; Horowski, R.; Jähnichen, S.; Görnemann, T.; Tack, J.; Pertz, H.H. 2006: Proterguride, a highly potent dopamine receptor agonist promising for transdermal administration in Parkinson's disease: interactions with alpha(1)-, 5-HT(2)- and H(1)-receptors. Life Sciences 78(20): 2358-2364
Simmons, D.C. 1963: Protest Humor: Folkloristic Reaction to Prejudice. American Journal of Psychiatry 120: 567-570
House, W. 2003: Protest about the GP contract. British Journal of General Practice: the Journal of the Royal College of General Practitioners 53(497): 972
Hoyer, H. 1958: Protest against the omnipotence of tablets. Hippokrates 29(6): 187
Berry, C.E. 1960: Protest concluded. Hospital Progress 41: 99
Berry, C.E. 1960: Protest continued. Hospital Progress 41: 20-22
Sharrar, C.W. 2006: Protest nursing issues when speaking out as a nurse. Rn 69(4): 12
Berry, C.E. 1960: Protest recorded. Hospital Progress 41: 110-111
Borrey, F. 1958: Health problems in the Sahara. Techniques Hospitalieres Medico-Sociales et Sanitaires 13(154): 51-53
Childress, J.F. 2002: Protestant perspectives on informed consent (particularly in research involving human participants). Fordham Urban Law Journal 30(1): 187-205
Cohen, C.B. 2002: Protestant perspectives on the uses of the new reproductive technologies. Fordham Urban Law Journal 30(1): 135-145
Charles, J.D. 2002: Protestant reflections on Salvifici doloris. National Catholic Bioethics Quarterly 2(2): 211-220
Reeves, R.B. 1961: Protestant views on cosmetic surgery. Eye Ear Nose and Throat Monthly 40: 856-858
Sister CATHERINE OF SIENNA 1962: Protestant-Catholic hospital dialogue. Hospital Progress 43: 66-68 Passim
Anonymous 2003: Protesters question G-8 pledge to fight AIDS at summit. Aids Policy and Law 18(12): 2
O'Brien, R. 2006: Protestors show ageism. Nursing New Zealand 12(6): 6
Pandey, K. 2006: Protests and bombing disrupt health care in Nepal. Bmj 332(7549): 1052
Watts, J. 2007: Protests in China over suspicions of a pay-or-die policy. Lancet 369(9556): 93-94
Anonymous 2003: Protests launched against Cirque du Soleil for HIV bias. Aids Policy and Law 18(21): 2
Knudson, A.G.; Knudson, A.G. 2005: A personal sixty-year tour of genetics and medicine. Annual Review of Genomics and Human Genetics 6(8): 1-14
Kapidzic, M.; Pophristov, T. 1964: Proteus Infection with Special Reference to a Case of Infection of Gynecological Origin. Medicinski Arhiv 18: 57-62
Zujovic, J.; Petrovic, L.; Kragujevic, D.; Milosevic, V. 1963: Proteus Infections in Infants and small Children. Srpski Arhiv Za Celokupno Lekarstvo 91: 661-668
Beurey, J.; Dureux, J.B.; Weber, M.; Druesne, M.; Petitjean, J. 1964: Proteus Vulgaris Septicemia: Severe Complications of a Leg Ulcer. Bulletin de la Societe Francaise de Dermatologie et de Syphiligraphie 71: 239-242
Sarrouy, C.; Cabannes, R.; Sabatini, R. 1955: Proteus and infant diarrhea; preliminary note. Pediatrie 10(6): 671-674
Holloway, W.J.; Scott, E.G. 1957: Proteus bacteremia treated with large doses of penicillin. Antibiotic Medicine and Clinical Therapy 4(2): 104-107
Hanikova, Z.; Forejtova, B. 1960: Proteus in normal and pathological material in children. Ceskoslovenska Pediatrie 15: 901-904
Scotti, G.; Sicca, G.T. 1951: Proteus in the etiology of food poisoning; case report of an attack due to Proteus morganii. Minerva Medica 42(61): 341-344
Pelkowitz, D. 1959: Proteus infections succesfully treated in general practice with bicillin and streptomycin. South African Medical Journal 33(13): 267-268
Naranjo Granda, F.B.; Ruiz Sanchez, A.; Ruiz Sanchez, F. 1956: Proteus invasion of the intestinal cavity in patients treated with antibiotics; Proteus sensitivity to antibacterial medication. Medicina 36(752): 329-332
Tolmas, H.C.; Winter, J. 1957: Proteus meningitis; report of a case in a newborn caused by Proteus mirabilis. A.M.A. Journal of Diseases of Children 94(5): 574-576
Chandrashekara, S.; Ramesh, M.N.; Shobha, A.; Saravanan, Y.; Vadiraja, H.S.; Navaneeth, B.V.; Sandhya Belwadi, M.R. 2003: Proteus mirabilis and rheumatoid arthritis: no association with the disease. Clinical Rheumatology 22(4-5): 268-270
Villamil Cajoto, I.; Van den Eynde Collado, A.; Villacián Vicedo, M.J.; Martínez Rey, C.; Rodríguez Otero, L.; Rodríguez Framil, M. 2006: Proteus mirabilis community-acquired pneumonia. Anales de Medicina Interna 23(3): 146
Zunino, P.; Sosa, V.; Allen, A.G.; Preston, A.; Schlapp, G.; Maskell, D.J. 2003: Proteus mirabilis fimbriae (PMF) are important for both bladder and kidney colonization in mice. Microbiology 149(Part 11): 3231-3237
Charocopos, S.; Sakelaridis, N.; Giogarakis, T. 1963: Proteus mirabilis meningitis. Archives Francaises de Pediatrie 20: 731-734
Joshi, B.N.; Moses, J.M.; Gadgil, R.K. 1961: Proteus morgani as an etiological agent in meningitis. Case report. Indian Journal of Medical Sciences 15: 862-865
Cantón, R.; Sánchez-Moreno, M.P.; Morosini Reilly, M.ía.I. 2006: Proteus penneri. Enfermedades Infecciosas y Microbiologia Clinica 24(Suppl 1): 8-13
Dragieva, G.; Stahel, H.U.; Meyer, M.; Kempf, W.; Häffner, A.; Burg, G.; Hafner, J. 2003: Proteus syndrome. Vasa. Zeitschrift für Gefasskrankheiten 32(3): 159-163
Cardoso, M.T.; de Carvalho, T.B.; Casulari, L.A.; Ferrari, I. 2003: Proteus syndrome and somatic mosaicism of the chromosome 16. Panminerva Medica 45(4): 267-271
Yosunkaya Fenerci, E.; Değirmenci, S.; Yeşil, G.; Yüksel, A. 2006: Proteus syndrome with agenesis of the rectus abdominis. British Journal of Dermatology 155(5): 1094-1095
Badia, M.C.; Chamarro, R.; Làinez, J.M.; Piera, A. 2006: Proteus syndrome with cerebral vascular malformations. Neurologia 21(2): 88-91
Matsumoto, S.; Takahashi, S.; Goto, T.; Tomita, K.; Takeuchi, T.; Kitamura, T. 2005: Proteus syndrome with giant myelolipoma in the pelvis. International Journal of Urology: Official Journal of the Japanese Urological Association 12(11): 1005-1006
Rao, G.S.; Vohra, D. 2003: Proteus syndrome with gingival hyperplasia. International Journal of Dermatology 42(10): 826-828
Pradhan, A.; Sen, I.; Batra, Y.K.; Biswas, G. 2003: Proteus syndrome: a concern for the anesthesiologist. Anesthesia and Analgesia 96(3): 915-916
Joshi, U.; van der Sluijs, J.A.; Teule, G.J.J.; Pijpers, R. 2005: Proteus syndrome: a rare cause of hemihypertrophy and macrodactyly on bone scanning. Clinical Nuclear Medicine 30(9): 604-605
Velázquez Fragua, R.; Pascual-Castroviejo, I. 2003: Proteus syndrome: report of two cases. Anales de Pediatria 58(5): 496-501
Murphy, G.P.; McDONALD, D.F. 1961: Proteus, Pseudomonas and Achromobacter septicemias as complications of chronic infection in anatomically predisposed urinary tracts. Journal of Urology 85: 672-675
Pacheco, L.; Riba, R.ón. 2003: Prothallia in nine species of Callipteris and its comparison with other genera of the Woodsiaceae family. Revista de Biologia Tropical 51(1): 49-57
Perret, P. 1964: Prothesis in the Surgery of Otosclerosis. Practica Oto-Rhino-Laryngologica 26: 195-201
Donati Von Gralath, R. 1960: Prothesis and epithesis for the repair of acquired and congenital defects of the nose. Minerva Chirurgica 15: 1040-1047
Vencovsky, E.; Sedivec, V.; Peterova, E.; Janovsky, F.; Dvorakova, M.; Baudis, P. 1964: Prothiadine in Psychiatric Work. Ceskoslovenska Psychiatrie 60: 416-418
Cohen, S.; Ditman, K.S.; Mooney, H.B.; Whittlesey, J.R. 1961: Prothipendyl (Timovan) in the treatment of alcoholism: preliminary report. Journal of New Drugs 1: 235-237
Nehlil, J.; Metral, S.; Rouyer 1962: Prothipendyl hydrochloride in psychiatric practice. Annales Medico-Psychologiques 120(1): 959-962
Hift, S.; Kryspin-Exner, K. 1958: Prothipendyl-hydrochloride, a new neuroleptic. Wiener Medizinische Wochenschrift 108(32): 664-668
Senevet, G.; Andarelli, L.; Graells, R. 1957: Prothoracic dorsal hairs in Culex larvae. Archives de l'Institut Pasteur d'Algerie 35(2): 90-98
Bradleigh Vinson, S.; Malva, C.; Paola Varricchio; Sordetti, R.; Falabella, P.; Pennacchio, F. 1998: Prothoracic gland inactivation in Heliothis virescens (F.) (Lepidoptera:Noctuidae) larvae parasitized by Cardiochiles nigriceps Viereck (Hymenoptera:Braconidae). Journal of Insect Physiology 44(9): 845-857
Mizoguchi, A.; Ishizaki, H. 1982: Prothoracic glands of the saturniid moth Samia cynthia ricini possess a circadian clock controlling gut purge timing. Proceedings of the National Academy of Sciences of the United States of America 79(8): 2726-2730
Desimoni, G.; Frisani, G.; Demarinis, A. 1964: Prothrombin (Quick) time and Plasma Fibrinogen in Subjects affected by Pulmonary Tuberculosis Treated by Corticotherapy and Chemoantibiotic Therapy. Lotta Contro la Tubercolosi 34: 1047-1051
Maruyama, I. 2004: Prothrombin (factor II) and prothrombin fragment 1+2 (F1+2). Nihon Rinsho. Japanese Journal of Clinical Medicine 62(Suppl 12): 623-625
Karagulle, E.; Turk, E.; Gokturk, H.Savas.; Yildirim, E.; Moray, G. 2007: Prothrombin 20210 G/A defect as a cause of mesenteric venous infarction: report of a case. Surgery Today 37(3): 251-253
Gadelha, T.; André, C.; Jucá, A.A.V.; Nucci, M.ár. 2005: Prothrombin 20210A and oral contraceptive use as risk factors for cerebral venous thrombosis. Cerebrovascular Diseases 19(1): 49-52
Zivelin, A.; Mor-Cohen, R.; Kovalsky, V.; Kornbrot, N.; Conard, J.; Peyvandi, F.; Kyrle, P.A.; Bertina, R.; Peyvandi, F.; Emmerich, J.; Seligsohn, U. 2006: Prothrombin 20210G>A is an ancestral prothrombotic mutation that occurred in whites approximately 24,000 years ago. Blood 107(12): 4666-4668
Martinelli, I.; Battaglioli, T.; Tosetto, A.; Legnani, C.; Sottile, L.; Ghiotto, R.; Mannucci, P.M. 2006: Prothrombin A19911G polymorphism and the risk of venous thromboembolism. Journal of Thrombosis and Haemostasis: Jth 4(12): 2582-2586
Purcell, G.M.; Barnhart, M.I. 1963: Prothrombin Activation with Cathepsin C. Biochimica et Biophysica Acta 78: 800-802
Tolstova, T.I.; Protoklitova, N.S. 1964: Prothrombin and Proconvertin Indices in Botkin's Disease in Children. Voprosy Okhrany Materinstva i Detstva 9: 38-41
Yamanaka, M.; Izuki, Y.; Isobe, H. 1963: Prothrombin Consumption Test--By the Thrombotest Method; Several Studies. Rinsho Byori. Japanese Journal of Clinical Pathology 11: 664-669
Reshetkina, L.P. 1963: Prothrombin Formation Function of the Liver during Acute Digestive Disorders in the Early Infantile Age. Pediatriia 42: 29-33
Garewal, G.; Das, R.; Ahluwalia, J.; Mittal, N.; Varma, S. 2003: Prothrombin G20210A is not prevalent in North India. Journal of Thrombosis and Haemostasis: Jth 1(10): 2253-2254
Andrew, T.A.; Fairweather, R. 2003: Prothrombin G20210A mutation and sudden death. American Journal of Forensic Medicine and Pathology 24(4): 377-380
Lichy, C.; Reuner, K.H.; Buggle, F.; Litfin, F.; Rickmann, H.; Kunze, A.; Brandt, T.; Grau, A. 2003: Prothrombin G20210A mutation, but not factor V Leiden, is a risk factor in patients with persistent foramen ovale and otherwise unexplained cerebral ischemia. Cerebrovascular Diseases 16(1): 83-87
Glueck, H.I.; Sutherland, J.; Gleser, G. 1964: Prothrombin Levels during the first year of Life. Observations Followed by the Synthetic Substrate (Tame) Assay of Normal Full-Term Infants. American Journal of Diseases of Children 107: 612-617
Penner, J.A. 1964: Prothrombin Levels in Serum. Thrombosis et Diathesis Haemorrhagica 10: 332-349
Reshetkina, L.P. 1963: Prothrombin Production Function of the Liver in Infants during Toxic Conditions of Enteral and Parenteral Origin. Pediatriia Akusherstvo i Ginekologiia 58: 22-23
Wang, W.; Fu, Q.; Zhou, R.; Wu, W.; Ding, Q.; Hu, Y.; Wang, X.; Wang, H.; Wang, Z. 2004: Prothrombin Shanghai: hypoprothrombinaemia caused by substitution of Gla29 by Gly. Haemophilia: the Official Journal of the World Federation of Hemophilia 10(1): 94-97
François, D.; Chevreaud, C.; Vignon, D.; de Mazancourt, P. 2006: Prothrombin Suresnes: a case of homozygous F299V mutation responsible for hypodysprothrombinemia. Haematologica 91(3): 431-432
Luddecke, H.F.; Breuchaud, J.S.; Lenahan, J.G.; Phillips, G.E. 1965: Prothrombin Times on Aged Plasma: a Critical Evaluation of a new Reagent. American Journal of the Medical Sciences 250: 8-10
Inceman, S. 1954: Prothrombin acceleration factors. Tip Fakultesi Mecmuasi 17(1): 38-47
Fantl, P.; Sawers, R.J. 1956: Prothrombin accelerator deficiency associated with tuberculosis. Medical Journal of Australia 43(13): 536-541
Castellani, L.; Bertola, G. 1957: Prothrombin activity and its changes after vitamin K load in old age. Archivio "e. Maragliano" di Patologia E Clinica 13(6): 1571-1576
Gaglio, M. 1953: Prothrombin activity and prothrombin residue in subjects treated with irgapyrine. Reumatismo 5(Suppl. 2): 135-137
Datta, H. 1962: Prothrombin activity in haemorrhagic disease of the newborn with reference to mothers with toxaemia of pregnancy. Journal of the Indian Medical Association 38: 108-112
Bocchetti, G. 1952: Prothrombin activity of preserved human blood in relation to the anticoagulant used. Annali Italiani di Chirurgia 29(3): 156-166
Maliarovskii, V.N. 1960: Prothrombin activity of the blood and tolerance of the plasma to heparin in stenocardia and myocardial infarct. Terapevticheskii Arkhiv 32: 73-75
Schultze, H.E. 1950: Prothrombin and Seegers' accelerator globulin. Deutsche Medizinische Wochenschrift 75(18): 607-611
Van Creveld, S.; Paulssen, P.; Teng, S.K. 1952: Prothrombin and accelerator globulin in the plasma of newborns under normal and pathological conditions. Etudes Neo-Natales. Neo-Natal Studies 1(4): 87-101
Salazar De Sousa, C.; Crespo Ferreira, J.; Ferreira Gomes, A.; Estrela, A. 1953: Prothrombin and accelerin in the blood of the newborn. Archives Francaises de Pediatrie 10(5): 464-473
Owren, P.A. 1953: Prothrombin and accessory factors; clinical significance. American Journal of Medicine 14(2): 201-215
Dal Santo, G. 1952: Prothrombin and anemia. Rassegna Medica Sarda 54(11-12(Suppl): 29-36
Su, Z.; Izumi, T.; Ortel, T.L. 2003: Prothrombin and beta 2-glycoprotein I frequently contribute to antiphospholipid antibody interactions with phospholipids and the generation of abnormal waveform profiles in coagulation assays. Thrombosis and Haemostasis 90(2): 218-226
Koller, F.; Held, E. 1952: Prothrombin and factor 7 content of blood at the end of pregnancy and in newborn. Gynaecologia. International Monthly Review of Obstetrics and Gynecology. Revue Internationale Mensuelle d'Obstetrique et de Gynecologie. Monatsschrift für Geburtshilfe und Gynakologie 134(1): 43-46
Fradkina, V.E. 1956: Prothrombin and fibrinogen levels in myocardial infarct and stenocardia. Terapevticheskii Arkhiv 28(6): 32-39
Donald, A.C.; Hunter, R.B.; Tudhope, G.R.; Walker, W.; Whitton, I. 1954: Prothrombin and haemorrhage. British Medical Journal 2(4894): 961-963
Lazarou, P. 1961: Prothrombin and hemorragic complications in tuberculosis. Apropos of 997 patients. Acta Tuberculosea Scandinavica 40: 251-289
Ulutin, O.N. 1962: Prothrombin and its derivatives. Turk Tip Cemiyeti Mecmuasi 28: 242-247
Carbajal, B. 1959: Prothrombin and its modification in therapy with anticoagulants. El Dia Medico 31: 1929-1936
Papayannopoulos, G. 1949: Prothrombin and liver diseases. Medizinische Monatsschrift 3(12): 923
Dyggve, H. 1958: Prothrombin and proconvertin in the newborn and during the first year of life. Acta Paediatrica 47(3): 251-259
Familiari, R.; Ursini, M. 1951: Prothrombin and prothromboplastin time following splenectomy; experimental and clinical study. Rassegna Internazionale di Clinica E Terapia 31(21): 613-621
Glynn, J.C.; Plaat, F. 2007: Prothrombin complex for massive obstetric haemorrhage. Anaesthesia 62(2): 202-203
Paraf, A. 1955: Prothrombin complex in functional examination of liver cells. La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 31(28): 1628
Brichta, G.; Kuhbock, J.; Reimer, E.E. 1958: Prothrombin consumption and the bromsulphalein test in blood diseases. Ii. Deutsches Archiv für Klinische Medizin 205(3): 310-315
MacMILLAN, R.L.; Ezrin, C.; Butler, A. 1951: Prothrombin consumption in haemophiliac kindred. Journal of Clinical Pathology 4(4): 460-463
Hule, V. 1955: Prothrombin consumption test, its clinical significance and affecting factors. Vnitrni Lekarstvi 1(4): 253-257
Panini, F. 1950: Prothrombin content of the blood in normal and pathological pregnancy. Archivio di Ostetricia E Ginecologia 55(1): 55-70
Mueller, J.; Duckert, F. 1961: Prothrombin conversion in the intravascular system. Schweizerische Medizinische Wochenschrift 91: 1140-1141
Stanchev, H.; Philips, M.; Villoutreix, B.O.; Aksglaede, L.; Lethagen, S.; Thorsen, S. 2006: Prothrombin deficiency caused by compound heterozygosity for two novel mutations in the prothrombin gene associated with a bleeding tendency. Thrombosis and Haemostasis 95(1): 195-198
Wang, W.-b.; Wang, H.-l.; Huang, C.-y.; Fang, Y.; Fu, Q.-h.; Zhou, R.-f.; Xie, S.; Ding, Q.-l.; Wu, W.-m.; Wang, X.-f.; Hu, Y.-q.; Wang, Z.-y. 2003: Prothrombin deficiency resulted from a homozygous Glu29 to Gly mutation in the prothrombin gene. Zhonghua Xue Ye Xue Za Zhi 24(9): 449-451
Horsfall, W.R. 1957: Prothrombin depressants and sodium fluoracetate in rat control. Medical Journal of Australia 44(15): 542-544
Crolle, G.; Boglione, F. 1953: Prothrombin determination. Bollettino della Societa Italiana di Biologia Sperimentale 29(2): 184-186
Bernier, J.J. 1953: Prothrombin determination and heparin tolerance test; tests for control of phlebitis. Concours Medical 75(44): 3653-3656
Hecht, E. 1953: Prothrombin determination and thrombokinase. Nederlands Tijdschrift Voor Geneeskunde 97(30): 1966-1968
Perlick, E. 1951: Prothrombin determination as a liver function test. Zeitschrift für die Gesamte Experimentelle Medizin 116(6): 540-544
Etess, A.D.; Sussman, L.N. 1954: Prothrombin determination at 4 degrees C; its use as a bedside test. United States Armed Forces Medical Journal 5(9): 1309-1314
Pigeaud, H.; Neumann, E.; Barbaud 1953: Prothrombin determination during the first ten days in full term newborn and in premature. Lyon Medical 189(31): 65-72
Conrad, K.; Domanowsky, K.; Ott, B. 1954: Prothrombin determination in acute catatonia. Medizinische Klinik 49(17): 673-677
Tronnberg, G. 1955: Prothrombin determination in combined treatment with heparin and drugs of the dicumarol type. Nordisk Medicin 53(26): 1028-1029
Bjornesjo, K.B.; Karlstrom, F. 1958: Prothrombin determination in infants: a comparison of the methods of Quick-Lehmann and Owren. Acta Paediatrica 47(6): 626-634
Lewis, D.W.; Munro, F.L.; Munro, M.P. 1950: Prothrombin determinations in dicumarolized patients; a comparison of the one-stage and bedside methods. Journal of Laboratory and Clinical Medicine 35(1): 16-23
McCLORRY, R.G. 1954: Prothrombin estimation; a review and discussion. Canadian Journal of Medical Technology 16(2): 37-47
Larsen, E.H. 1952: Prothrombin fluctuations in newborn, with an analysis of the technique and value of prothrombin determination. Nordisk Medicin 48(36): 1251
Ozdag, H.; Egin, Y.; Akar, N. 2006: Prothrombin gene 20209 C >T along with the first description of a homozygous polymorphism at the 3' downstream region +4 C >T in the Turkish population. Laboratory Hematology: Official Publication of the International Society for Laboratory Hematology 12(3): 131-133
Schrijver, I.; Lenzi, T.J.; Jones, C.D.; Lay, M.J.; Druzin, M.L.; Zehnder, J.L. 2003: Prothrombin gene variants in non-Caucasians with fetal loss and intrauterine growth retardation. Journal of Molecular Diagnostics: Jmd 5(4): 250-253
Kove, S.; Benton, C. 1950: Prothrombin in the newborn infant. V. Further observations on the nature of prothrombin in the newborn infant: comparative effect of storage on prothrombin of the newborn infant and normal adult. Journal of Pediatrics 37(1): 78-89
Kove, S.; Benton, C. 1950: Prothrombin in the newborn infant. VI. Effect of sulfadiazine on prothrombin of the newborn infant. Journal of Pediatrics 37(1): 90-93
Norwiit, L.; Carstensen, B. 1953: Prothrombin index during PAS therapy. Nordisk Medicin 49(8): 303
Hallman, N.; Kauhtio, J. 1949: Prothrombin index of infants in severe gastroenteritis. Annales chirurgiae et gynaecologiae Fenniae. Supplementum 38(3): 48-60
Kovaleva, E.V. 1954: Prothrombin index of the blood in rheumatism in children. Pediatriia 1: 16-20
Averina, R.I. 1958: Prothrombin level and blood coagulability during salicylate therapy. Klinicheskaia Meditsina 36(3): 33-38
Forattini, C.; Pradelli, E. 1951: Prothrombin level and heparin activity of the plasma in hyperthyroidism. Folia Endocrinologica; Mensile di Incretologia E Incretoterapia 4(5): 643-649
Szirmai, E.; Nyiri, I. 1953: Prothrombin level change during treatment of acute and subacute regional inflammations. (Prognostic significance of prothrombin level). Magyar Noorvosok Lapja 16(3-4): 86-88
Tawast, M.; Siurala, M. 1955: Prothrombin level during phenylindandione therapy; influence of the condition of the liver. Annales Medicinae Internae Fenniae 44(4): 237-243
Tropeano, L. 1952: Prothrombin level in hemophilic blood after the addition in vitro of Cohn's fraction Ia (antihemophilic globulin). Bollettino della Societa Italiana di Biologia Sperimentale 28(12): 1892-1894
Tropeano, L. 1952: Prothrombin level in hemophilic blood after the intravenous injection of protamine sulfate and after transfusion with fresh blood. Bollettino della Societa Italiana di Biologia Sperimentale 28(12): 1894-1896
Tropeano, L. 1952: Prothrombin level in hemophilic blood and in hemophilic-like blood after the addition in vitro of fresh normal blood. Bollettino della Societa Italiana di Biologia Sperimentale 28(12): 1890-1892
Fucik, M.; Gregor, O.; Soukupova, K. 1952: Prothrombin level in peptic ulcer. Sbornik Pro Pathofysiologii Traveni a Vyzivy; Gastroenterologia Bohema 6(4-6): 283-286
Szirmai, E. 1951: Prothrombin level in the menstrual cycle, and the correlation of age to the menstrual blood volume and duration of menstruation. Orvosi Hetilap 92(45): 1456-1459
Pigeaud, H.; Nelken, S.; Bohe, H. 1954: Prothrombin level in the newborn after intravenous injection of synthetic vitamin K in the mother during labor. La Presse Medicale 62(54): 1123
Kaniak, J.; Leonow, A. 1951: Prothrombin level in thromboangiitis obliterans treated by insulin-induced hypoglycemia. Polski Tygodnik Lekarski 6(45-46): 1489-1497
Pigeaud, H.; Charvet, F.; Ricard, A. 1951: Prothrombin levels in normal women during the puerperium. Lyon Medical 184(12): 193-195
Jenkins, G.D. 1955: Prothrombin levels in post prostatic resection bleeding. Postgraduate Seminar. American Urological Association. North Central Section 1955: 139-141
Nasilowski, W. 1950: Prothrombin levels in postoperative states. Polski Tygodnik Lekarski 5(19): 735-742
Dreskin, O.H. 1958: Prothrombin measurement by two-stage technique with hemolyzed whole blood thromboplastin. Journal of Laboratory and Clinical Medicine 51(2): 313-316
Grundman, C.; Plesker, R.; Kusch, M.; Hanschmann, K.M.; Eich, S.; Seitz, R.; König, H. 2005: Prothrombin overload causes thromboembolic complications in prothrombin complex concentrates: in vitro and in vivo evidence. Thrombosis and Haemostasis 94(6): 1338-1339
Osechenskaia, G.V. 1950: Prothrombin production function of the liver in patients with leukosis. Klinicheskaia Meditsina 4: 91
Lockhart, J. 1954: Prothrombin studies in pediatrics. Clinical Proceedings - Children's Hospital of the District of Columbia 10(7): 127-131
Kok, K. 1955: Prothrombin test during oral treatment with anticoagulants. Nederlands Tijdschrift Voor Geneeskunde 99(19): 1374-1381
Giuseppe, P.; Silvia, J. 1957: Prothrombin time and vitamin K1 in the premature infant. La Clinica Pediatrica 39(10): 787-795
Ronco, P. 1952: Prothrombin time after alcohol surcharge in alcoholism. Rassegna di Studi Psichiatrici 41(3): 305-308
Cernelc, M. 1952: Prothrombin time and factor V. Zdravstveni Vestnik 21(7-8): 128-132
Van Cauwenberge, H.; Jaques, L.B. 1959: Prothrombin time and hemorrhagic death in dicumarolized rats receiving pituitary and adrenal hormones. Thrombosis et Diathesis Haemorrhagica 3(1): 45-58
Sigg, B. 1952: Prothrombin time and heparin intolerance test in hypercoagulability of the blood. Schweizerische Medizinische Wochenschrift 82(30): 762-764
Cermak, L.; Hobza, A.; Pokorny, J. 1956: Prothrombin time and heparin time during pelentan therapy. Polski Tygodnik Lekarski 11(37): 1577-1578
Orlova, E.A. 1953: Prothrombin time and significance of its determination. Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 53(12): 957-963
Trincao, C.; Franco, A.; Gouveia, E.; Parreira, F. 1953: Prothrombin time and test of induced hypoprothrombinemia in sleeping sickness. Anais do Instituto de Medicina Tropical 10(1): 11-14
Perlick, E. 1951: Prothrombin time as a liver function test. Klinische Wochenschrift 29(33-34): 577-578
Bocchetti, G.; Fiordigiglio, G. 1952: Prothrombin time before and after blood transfusion. Annali Italiani di Chirurgia 29(10): 661-670
Ronco, P. 1952: Prothrombin time before and after cardiazol shock. Giornale di Psichiatria E di Neuropatologia 80(2): 213-217
Biedermann, F. 1953: Prothrombin time determination and anticoagulant therapy in the small clinic. Deutsche Medizinische Wochenschrift 78(9): 304-306
Overman, R.S.; Wright, I.S. 1951: Prothrombin time determinations on patients with myocardial infarction. Journal of the American Medical Association 147(3): 227-229
Ronco, P. 1952: Prothrombin time during electronarcosis. Giornale di Psichiatria E di Neuropatologia 80(2): 203-206
Ronco, P. 1952: Prothrombin time during insulin coma. Giornale di Psichiatria E di Neuropatologia 80(2): 197-201
Norviit, L.; Cartensen, B. 1953: Prothrombin time during para-aminosalicylic acid therapy; two thousand determinations in 400 patients. American Review of Tuberculosis 67(2): 258-260
Bay, M.W.; Katz, A.D.; Strauss, L. 1957: Prothrombin time during the postoperative period. American Journal of Surgery 93(1): 95-101
Larsen, E.H. 1952: Prothrombin time fluctuations in newborn with an analysis of the technique and evaluation of prothrombin time determination. Ugeskrift for Laeger 114(23): 747-748
Kozlovskii, V.N. 1957: Prothrombin time function test of the liver and its prognostic significance in Botkin's disease. Klinicheskaia Meditsina 35(8): 100-104
Karner, A. 1953: Prothrombin time in Salmonella infections. Wiener Zeitschrift für Innere Medizin und ihre Grenzgebiete 34(11): 430-432
Ronco, P. 1953: Prothrombin time in acetylcholine shock. Giornale di Psichiatria E di Neuropatologia 81(1): 119-126
Sterne, J. 1954: Prothrombin time in acute articular rheumatism. Archives des Maladies du Coeur et des Vaisseaux 47(3): 257-262
Ofstad, J. 1958: Prothrombin time in acute gastrointestinal hemorrhage. Nordisk Medicin 60(49): 1754-1758
Konig, A. 1954: Prothrombin time in animal experiment and strophanthin effect. Zeitschrift für die Gesamte Experimentelle Medizin 124(6): 481-486
Milletti, A.; Di Paolo, E. 1951: Prothrombin time in bone marrow blood compared with peripheral blood. Haematologica 35(2): 177-189
Calogera, E. 1953: Prothrombin time in electric injuries. Folia Medica. Folia Medica 36(2): 80-84
Ronco, P. 1952: Prothrombin time in electroshock. Giornale di Psichiatria E di Neuropatologia 80(2): 207-212
Orekhova, A.A. 1953: Prothrombin time in mothers during labor and in newborn infants and its modifications following administration of vikasol; experimental and clinical studies. Trudy. Institut Grudnoi Khirurgii 29: 86-96
Racheva, B.; Romanov, M.G. 1954: Prothrombin time in newborn and significance of vitamin K in prevention and therapy of intracranial hemorrhages. Suvremenna Meditsina 5(11): 95-101
Bojanowica, D.; Olszewski, W. 1952: Prothrombin time in ostructive and parenchymatous jaundice; effect of short-term sleep. Polski Tygodnik Lekarski 7(45): 1474
Beltran, J.; Salgado Lanza, A.; Garcia, P.E. 1955: Prothrombin time in premature newborn infants; study on 100 cases. Archivos de Pediatria del Uruguay 26(9): 863-867
Ingrao, F.; Boccitto, G. 1951: Prothrombin time in pulmonary tuberculosis subjected to surgical collapse therapy. Annali Dell'istituto "carlo Forlanini" 13(1): 74-86
Coppola, C.F.; Pannuti, M. 1954: Prothrombin time in schizophrenics. L'Ospedale Psichiatrico 22(4): 384-390
Zvonareva, V.V. 1958: Prothrombin time in some infectious diseases. Klinicheskaia Meditsina 36(3): 121-124
Burstein, M. 1950: Prothrombin time in the presence of a heterologous thromboplastin. Revue d'Hematologie 5(2): 180-187
Cognasso, A.; Perna, F. 1952: Prothrombin time in trilene anesthesia. Giornale Italiano di Anestesiologia 18(3): 355-362
Copaitich, T.; Giarrizzo, R. 1954: Prothrombin time in tuberculous meningitis treated with isoniazid. La Rassegna di Clinica Terapia e Scienze Affini 53(3): 138-142
Bertoni, L.; Dazzi, L. 1953: Prothrombin time in typhus patients treated with chloramphenicol. Il Policlinico. Sezione Pratica 60(12): 412-417
Tripodi, A. 2004: Prothrombin time international normalized ratio monitoring by self-testing. Current Opinion in Hematology 11(3): 141-145
Bergman, I.; Young, Y. 2007: Prothrombin time is not the whole story. Anaesthesia and Intensive Care 35(1): 140-1; author reply 141-2
Bernier, J.J. 1953: Prothrombin time test in liver insufficiency. Concours Medical 75(42): 3433-3438
Shahangian, S.; Labeau, K.M.; Howerton, D.A. 2006: Prothrombin time testing practices: adherence to guidelines and standards. Clinical Chemistry 52(5): 793-794
Nyiri, S. 1952: Prothrombin time tests in patients with genital carcinoma before and after roentgen therapy. Zentralblatt für Gynakologie 74(51): 2013-2018
Glover, R.P.; Kuzell, W.C. 1961: Prothrombin time. Determination by a whole blood micro-method for control of anticoagulant therapy. California Medicine 95: 24-29
Dam, H.; Søndergaard, E. 1954: Prothrombin times of mixtures of various types of plasmas with lowered prothrombin activity. Acta Physiologica Scandinavica 31(4): 376-383
Brichta, G.; Kuhbock, J.; Reimer, E.E. 1956: Prothrombin use and bromsulfalein test in blood diseases. Deutsches Archiv für Klinische Medizin 203(3): 312-318
Johnson, J.F.; Mammen, E.F.; Seegers, W.H. 1959: Prothrombin utilization following addition of platelet confactor i concentrates to hemophilic plasma. Thrombosis et Diathesis Haemorrhagica 3: 588-592
Passaro, G. 1955: Prothrombin, factor V and factor VIi in the newborn. Archivio Italiano di Pediatria e Puericoltura 17(1): 59-90
La Torretta, G. 1953: Prothrombin, labile factor, and residual prothrombin in hemorrhages in pregnancy. Archivio di Ostetricia E Ginecologia 58(3): 234-237
Lamberg, B.A.; Gordin, R.; Grasbeck, R. 1955: Prothrombin, lipoproteins and proteins in thyroid disorders. Nordisk Medicin 53(9): 356-359
Comninos, A.; Adamis, D. 1959: Prothrombin, proconvertin and fibrinogen in pregnancy. Revue Francaise de Gynecologie et d'Obstetrique 54(5): 367-372
Alekperov, M.A. 1955: Prothrombin-forming function of the liver and hemorrhagic syndrome in thyrotoxicosis. Problemy Endokrinologii i Gormonoterapii 1(4): 33-36
Iartseva, L.I. 1962: Prothrombin-forming function of the liver in patients with pneumoconiosis. Zdravookhranenie Kazakhstana 22(3): 21-25
Quick, A.J.; Hussey, C.V.; Geppert, M. 1963: Prothrombin: Analytical and Clinical Aspects. Comparison of the One- and Two-Stage Methods. American Journal of the Medical Sciences 246: 517-526
Quick, A.J. 1952: Prothrombin: physiology and deficient states. American Practitioner and Digest of Treatment 3(5): 397-402
Fabre, A. 1950: Prothrombin; its determination and significance. La Presse Medicale 58(46): 827
Gelli, G.; Raspi, E. 1957: Prothrombinemia after administration of vitamin K and tromexan in liver function tests of pulmonary tuberculosis patients. Archivio "e. Maragliano" di Patologia E Clinica 13(1): 13-21
Zaccarini, C.; Zotti, G.C. 1952: Prothrombinemia and blood coagulation in the evaluation of surgical risks. Acta Anaesthesiologica 3(2): 109-128
Gentili, A.; Bottone, E.; Tangheroni, W. 1952: Prothrombinemia and capillary fragility in the newborn. Minerva Pediatrica 4(4): 123-130
Gentili, A.; Tangheroni, W. 1952: Prothrombinemia and intestinal flora in newborn infants. Minerva Pediatrica 4(7): 279-287
Zaccarini, C.; Zotti, G.C. 1952: Prothrombinemia and surgical interventions. Acta Anaesthesiologica 3(3): 173-188
Costa, A.; Salgado, D.V. 1952: Prothrombinemia in acute gastrointestinal disturbances in early infancy. Pediatria Pratica 23(1): 21-30
Gasparri, F. 1952: Prothrombinemia in primary glaucoma; studies on 100 cases. Bollettino d'Oculistica 31(3): 175-195
Grivaux, M. 1950: Prothrombinemia in the newborn and the value of vitamin K therapy. La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 26(36): 1728
Soragni, E.; Rezza, E.; Gherardini, A. 1950: Prothrombinemia in tuberculous persons of various ages during treatment with paraaminosalicylic acid. Acta Paediatrica Latina 3(1): 58-69
Scardigli, G.; Mininni, G. 1950: Prothrombinemic curve of vitamin K load in normal subjects and in liver disease. Lo Sperimentale 100(3-6): 265-270
Scardigli, G.; Mininni, G. 1950: Prothrombinemic values in Flajani-Basedow disease. Folia Endocrinologica; Mensile di Incretologia E Incretoterapia 3(2): 225-234
Crawford, J.H.; Augustson, B.M. 2006: Prothrombinex use for the reversal of warfarin: is fresh frozen plasma needed?. Medical Journal of Australia 184(7): 365-366
Abu-Amero, K.K.; Bosley, T.M. 2006: Prothrombotic and atherosclerotic risk factors lack significance in NAION patients harbouring mitochondrial DNA mutations. British Journal of Ophthalmology 90(1): 119-120
Van Vliet, H.A.A.M.; Winkel, T.A.; Noort, I.; Rosing, J.; Rosendaal, F.R. 2004: Prothrombotic changes in users of combined oral contraceptives containing drospirenone and cyproterone acetate. Journal of Thrombosis and Haemostasis: Jth 2(11): 2060-2062
Auwerda, J.J.A.; Sonneveld, P.; de Maat, M.P.M.; Leebeek, F.W.G. 2007: Prothrombotic coagulation abnormalities in patients with newly diagnosed multiple myeloma. Haematologica 92(2): 279-280
Revel-Vilk, S.; Chan, A.; Bauman, M.; Massicotte, P. 2003: Prothrombotic conditions in an unselected cohort of children with venous thromboembolic disease. Journal of Thrombosis and Haemostasis: Jth 1(5): 915-921
Slooter, A.J.C.; Rosendaal, F.R.; Tanis, B.C.; Kemmeren, J.M.; van der Graaf, Y.; Algra, A. 2005: Prothrombotic conditions, oral contraceptives, and the risk of ischemic stroke. Journal of Thrombosis and Haemostasis: Jth 3(6): 1213-1217
Ruberg, F.L.; Loscalzo, J. 2002: Prothrombotic determinants of coronary atherothrombosis. Vascular Medicine 7(4): 289-299
Ağaoğlu, N.; Mustafa, N.A.; Türkyilmaz, S. 2003: Prothrombotic disorders in patients with mesenteric vein thrombosis. Journal of Investigative Surgery: the Official Journal of the Academy of Surgical Research 16(5): 299-304